Transcriptional	O
activation	O
by	O
a	O
matrix	B-protein
associating	I-protein
region-binding	I-protein
protein	I-protein
.	O

contextual	O
requirements	O
for	O
the	O
function	O
of	O
bright	B-protein
.	O

Bright	B-protein
(	O
B	B-protein
cell	I-protein
regulator	I-protein
of	I-protein
IgH	I-protein
transcription	I-protein
)	O
is	O
a	O
B	B-cell_type
cell	I-cell_type
-specific	O
,	O
matrix	B-protein
associating	I-protein
region-binding	I-protein
protein	I-protein
that	O
transactivates	O
gene	O
expression	O
from	O
the	O
IgH	B-DNA
intronic	I-DNA
enhancer	I-DNA
(	O
E	B-DNA
mu	I-DNA
)	O
.	O

We	O
show	O
here	O
that	O
Bright	B-protein
has	O
multiple	O
contextual	O
requirements	O
to	O
function	O
as	O
a	O
transcriptional	B-protein
activator	I-protein
.	O

Bright	B-protein
can	O
not	O
transactivate	O
via	O
out	O
of	O
context	O
,	O
concatenated	B-protein
binding	I-protein
sites	I-protein
.	O

Transactivation	O
is	O
maximal	O
on	O
integrated	O
substrates	O
.	O

Two	O
of	O
the	O
three	O
previously	O
identified	O
binding	B-DNA
sites	I-DNA
in	O
E	B-DNA
mu	I-DNA
are	O
required	O
for	O
full	O
Bright	B-protein
transactivation	O
.	O

The	O
Bright	B-protein
DNA	I-protein
binding	I-protein
domain	I-protein
defined	O
a	O
new	O
family	O
,	O
which	O
includes	O
SWI1	B-protein
,	O
a	O
component	O
of	O
the	O
SWI.SNF	B-protein
complex	I-protein
shown	O
to	O
have	O
high	O
mobility	O
group-like	O
DNA	O
binding	O
characteristics	O
.	O

Similar	O
to	O
one	O
group	O
of	O
high	B-protein
mobility	I-protein
group	I-protein
box	I-protein
proteins	I-protein
,	O
Bright	B-protein
distorts	O
E	B-DNA
mu	I-DNA
binding	I-DNA
site	I-DNA
-containing	O
DNA	O
on	O
binding	O
,	O
supporting	O
the	O
concept	O
that	O
it	O
mediates	O
E	B-DNA
mu	I-DNA
remodeling	O
.	O

Transfection	O
studies	O
further	O
implicate	O
Bright	B-protein
in	O
facilitating	O
spatially	O
separated	O
promoter-enhancer	O
interactions	O
in	O
both	O
transient	O
and	O
stable	O
assays	O
.	O

Finally	O
,	O
we	O
show	O
that	O
overexpression	O
of	O
Bright	B-protein
leads	O
to	O
enhanced	O
DNase	O
I	O
sensitivity	O
of	O
the	O
endogenous	O
E	B-DNA
mu	I-DNA
matrix	O
associating	O
regions	O
.	O

These	O
data	O
further	O
suggest	O
that	O
Bright	B-protein
may	O
contribute	O
to	O
increased	O
gene	O
expression	O
by	O
remodeling	O
the	O
immunoglobulin	B-DNA
locus	I-DNA
during	O
B	B-cell_type
cell	I-cell_type
development	O
.	O

THE	NULL
JOURNAL	NULL
oF	NULL
BIOLOGICAL	NULL
CHEMISTRY	NULL
©	NULL
2001	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
for	NULL
Biochemistry	NULL
and	NULL
Molecular	NULL
Biology	NULL
,	NULL
Inc.	NULL
Vol	NULL
.	NULL

276	NULL
,	NULL
No	NULL
.	NULL

24	NULL
,	NULL
Issue	NULL
of	NULL
June	NULL
15	NULL
,	NULL
pp	NULL
.	NULL

21325-21330	NULL
,	NULL
2001	NULL
Printed	NULL
in	NULL
U.S.A.	NULL
Transcriptional	NULL
Activation	NULL
by	NULL
a	NULL
Matrix	NULL
Associating	NULL
Region-binding	NULL
Protein	NULL
CONTEXTUAL	NULL
REQUIREMENTS	NULL
FOR	NULL
THE	NULL
FUNCTION	NULL
OF	NULL
BRIGHT*	NULL
Received	NULL
for	NULL
publication	NULL
,	NULL
January	NULL
29	NULL
,	NULL
2001	NULL
,	NULL
and	NULL
in	NULL
revised	NULL
form	NULL
,	NULL
March	NULL
30	NULL
,	NULL
2001	NULL
Published	NULL
,	NULL
JBC	NULL
Papers	NULL
in	NULL
Press	NULL
,	NULL
April	NULL
6	NULL
,	NULL
2001	NULL
,	NULL
DOI	NULL
10.1074/jbc.M100836200	NULL
Mark	NULL
H.	NULL
Kaplant	NULL
#	NULL
§	NULL
,	NULL
Rui-Ting	NULL
Zong+	NULL
}	NULL
,	NULL
Richard	NULL
F.	NULL
Herrschert	NULL
$	NULL
,	NULL
Richard	NULL
H.	NULL
Scheuermann	NULL
,	NULL
and	NULL
Philip	NULL
W.	NULL
Tucker	NULL
#	NULL
]	NULL
From	NULL
the	NULL
{	NULL
Institute	NULL
for	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
at	NULL
Austin	NULL
,	NULL
Austin	NULL
,	NULL
Texas	NULL
78712-1075	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
Southwestern	NULL
Medical	NULL
Center	NULL
,	NULL
Dallas	NULL
,	NULL
Texas	NULL
75235	NULL
Bright	NULL
(	NULL
B	NULL
cell	NULL
regulator	NULL
of	NULL
IgH	NULL
transcription	NULL
)	NULL
is	NULL
a	NULL
B	NULL
cell-specific	NULL
,	NULL
matrix	NULL
associating	NULL
region-binding	NULL
protein	NULL
that	NULL
transactivates	NULL
gene	NULL
expression	NULL
from	NULL
the	NULL
IgH	NULL
in-tronic	NULL
enhancer	NULL
(	NULL
Ep	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
Bright	NULL
has	NULL
multiple	NULL
contextual	NULL
requirements	NULL
to	NULL
function	NULL
as	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Bright	NULL
can	NULL
not	NULL
transactivate	NULL
via	NULL
out	NULL
of	NULL
context	NULL
,	NULL
concatenated	NULL
binding	NULL
sites	NULL
.	NULL

Transactivation	NULL
is	NULL
maximal	NULL
on	NULL
integrated	NULL
substrates	NULL
.	NULL

Two	NULL
of	NULL
the	NULL
three	NULL
previously	NULL
identified	NULL
binding	NULL
sites	NULL
in	NULL
Ep	NULL
are	NULL
required	NULL
for	NULL
full	NULL
Bright	NULL
transactivation	NULL
.	NULL

The	NULL
Bright	NULL
DNA	NULL
binding	NULL
domain	NULL
defined	NULL
a	NULL
new	NULL
family	NULL
,	NULL
which	NULL
includes	NULL
SWIL	NULL
,	NULL
a	NULL
component	NULL
of	NULL
the	NULL
SWI-SNF	NULL
complex	NULL
shown	NULL
to	NULL
have	NULL
high	NULL
mobility	NULL
group-like	NULL
DNA	NULL
binding	NULL
characteris-tics	NULL
.	NULL

Similar	NULL
to	NULL
one	NULL
group	NULL
of	NULL
high	NULL
mobility	NULL
group	NULL
box	NULL
proteins	NULL
,	NULL
Bright	NULL
distorts	NULL
Ep	NULL
binding	NULL
site-containing	NULL
DNA	NULL
on	NULL
binding	NULL
,	NULL
supporting	NULL
the	NULL
concept	NULL
that	NULL
it	NULL
mediates	NULL
Ep	NULL
remodeling	NULL
.	NULL

Transfection	NULL
studies	NULL
further	NULL
implicate	NULL
Bright	NULL
in	NULL
facilitating	NULL
spatially	NULL
separated	NULL
promoter-enhancer	NULL
interactions	NULL
in	NULL
both	NULL
transient	NULL
and	NULL
stable	NULL
assays	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
show	NULL
that	NULL
overexpression	NULL
of	NULL
Bright	NULL
leads	NULL
to	NULL
enhanced	NULL
DNase	NULL
I	NULL
sensitivity	NULL
of	NULL
the	NULL
endogenous	NULL
Ep	NULL
matrix	NULL
associating	NULL
regions	NULL
.	NULL

These	NULL
data	NULL
further	NULL
suggest	NULL
that	NULL
Bright	NULL
may	NULL
contribute	NULL
to	NULL
increased	NULL
gene	NULL
expression	NULL
by	NULL
remodeling	NULL
the	NULL
immunoglobulin	NULL
locus	NULL
during	NULL
B	NULL
cell	NULL
development	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
genes	NULL
during	NULL
development	NULL
and	NULL
differentiation	NULL
is	NULL
tightly	NULL
controlled	NULL
through	NULL
several	NULL
mecha-nisms	NULL
.	NULL

The	NULL
tissue	NULL
specificity	NULL
conferred	NULL
by	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
enhancer	NULL
(	NULL
Ep	NULL
)	NULL
has	NULL
been	NULL
studied	NULL
extensively	NULL
both	NULL
for	NULL
understanding	NULL
Ig	NULL
regulation	NULL
and	NULL
as	NULL
a	NULL
model	NULL
for	NULL
enhancer	NULL
function	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Ep	NULL
is	NULL
a	NULL
complex	NULL
unit	NULL
containing	NULL
binding	NULL
sites	NULL
for	NULL
multiple	NULL
transcription	NULL
factors	NULL
and	NULL
can	NULL
func-	NULL
*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
Grants	NULL
Al18016	NULL
and	NULL
CA31534	NULL
(	NULL
to	NULL
P.	NULL
W.	NULL
T.	NULL
)	NULL
and	NULL
GM50329	NULL
(	NULL
to	NULL
R.	NULL
H.	NULL
S.	NULL
)	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
adver-tisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

§	NULL
Present	NULL
address	NULL
:	NULL
Dept	NULL
.	NULL

of	NULL
Immunology	NULL
and	NULL
Microbiology	NULL
and	NULL
the	NULL
Walther	NULL
Oncology	NULL
Center	NULL
,	NULL
Indiana	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
,	NULL
Indi-anapolis	NULL
,	NULL
IN	NULL
46202	NULL
.	NULL

|	NULL
To	NULL
whom	NULL
correspondence	NULL
should	NULL
be	NULL
addressed	NULL
:	NULL
Inst	NULL
.	NULL

for	NULL
Molecular	NULL
and	NULL
Cellular	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
at	NULL
Austin	NULL
,	NULL
100	NULL
W	NULL
24th	NULL
St.	NULL
,	NULL
ESB-534	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
78712-1095	NULL
.	NULL

Tel	NULL
.	NULL

:	NULL
512-475-7705	NULL
;	NULL
Fax	NULL
:	NULL
512-475-7707	NULL
;	NULL
E-mail	NULL
:	NULL
philtucker	NULL
@	NULL
mail.utexas.edu	NULL
.	NULL

*	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
Ep	NULL
,	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
in-tronic	NULL
enhancer	NULL
;	NULL
MAR	NULL
(	NULL
s	NULL
)	NULL
,	NULL
matrix	NULL
attachment/associating	NULL
region	NULL
(	NULL
s	NULL
)	NULL
;	NULL
P	NULL
site	NULL
,	NULL
Bright/nuclear	NULL
factor-u	NULL
negative	NULL
regulator	NULL
binding	NULL
site	NULL
in	NULL
Ep	NULL
;	NULL
CAT	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
;	NULL
bp	NULL
,	NULL
base	NULL
pair	NULL
(	NULL
s	NULL
)	NULL
;	NULL
tk	NULL
,	NULL
thymidine	NULL
kinase	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
available	NULL
on	NULL
line	NULL
at	NULL
http	NULL
:	NULL
//www.jbc.org	NULL
tionally	NULL
be	NULL
broken	NULL
down	NULL
into	NULL
two	NULL
segments	NULL
,	NULL
the	NULL
core	NULL
and	NULL
the	NULL
flanking	NULL
matrix	NULL
associating	NULL
regions	NULL
(	NULL
MARs	NULL
)	NULL
(	NULL
2-5	NULL
)	NULL
.	NULL

Most	NULL
of	NULL
the	NULL
previously	NULL
identified	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
enhancer	NULL
core	NULL
,	NULL
and	NULL
several	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
have	NULL
some	NULL
B	NULL
cell	NULL
specificity	NULL
in	NULL
terms	NULL
of	NULL
expression	NULL
or	NULL
ability	NULL
to	NULL
transactivate	NULL
.	NULL

However	NULL
,	NULL
no	NULL
binding	NULL
site	NULL
in	NULL
isolation	NULL
can	NULL
confer	NULL
all	NULL
of	NULL
the	NULL
tissue-specific	NULL
regulation	NULL
seen	NULL
in	NULL
vivo	NULL
.	NULL

Ultimately	NULL
,	NULL
this	NULL
is	NULL
the	NULL
result	NULL
of	NULL
cumulative	NULL
interactions	NULL
of	NULL
various	NULL
nuclear	NULL
factors	NULL
with	NULL
both	NULL
DNA	NULL
and	NULL
each	NULL
other	NULL
.	NULL

The	NULL
Ep	NULL
core	NULL
segment	NULL
alone	NULL
can	NULL
increase	NULL
transcription	NULL
in	NULL
transient	NULL
systems	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
.	NULL

In	NULL
vivo	NULL
,	NULL
however	NULL
,	NULL
the	NULL
core	NULL
alone	NULL
is	NULL
insufficient	NULL
to	NULL
drive	NULL
transcription	NULL
or	NULL
maintain	NULL
tissue	NULL
specificity	NULL
.	NULL

Transgenic	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
high	NULL
level	NULL
tissue-specific	NULL
expression	NULL
is	NULL
only	NULL
seen	NULL
when	NULL
the	NULL
core	NULL
is	NULL
present	NULL
in	NULL
context	NULL
of	NULL
the	NULL
MARs	NULL
(	NULL
8	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
requires	NULL
the	NULL
core	NULL
,	NULL
because	NULL
MARs	NULL
alone	NULL
could	NULL
not	NULL
produce	NULL
high	NULL
level	NULL
expression	NULL
.	NULL

Although	NULL
the	NULL
MARs	NULL
had	NULL
previously	NULL
been	NULL
implicated	NULL
in	NULL
negative	NULL
regulation	NULL
of	NULL
the	NULL
Ig	NULL
locus	NULL
in	NULL
non-B	NULL
cells	NULL
(	NULL
4	NULL
,	NULL
9-12	NULL
)	NULL
,	NULL
this	NULL
was	NULL
the	NULL
first	NULL
demonstration	NULL
that	NULL
the	NULL
MARs	NULL
were	NULL
required	NULL
for	NULL
proper	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Bright	NULL
(	NULL
B	NULL
cell	NULL
regulator	NULL
of	NULL
IgH	NULL
transcription	NULL
)	NULL
is	NULL
the	NULL
only	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
shown	NULL
to	NULL
bind	NULL
to	NULL
,	NULL
and	NULL
transactivate	NULL
via	NULL
,	NULL
the	NULL
Ep	NULL
MARs	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Bright	NULL
was	NULL
first	NULL
identified	NULL
as	NULL
a	NULL
factor	NULL
responsible	NULL
for	NULL
increased	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy	NULL
chain	NULL
gene	NULL
following	NULL
antigen	NULL
+	NULL
interleukin	NULL
5	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
in	NULL
culture	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

The	NULL
Bright	NULL
binding	NULL
complex	NULL
has	NULL
also	NULL
recently	NULL
been	NULL
shown	NULL
to	NULL
contain	NULL
Btk	NULL
,	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
the	NULL
DNA	NULL
binding	NULL
complex	NULL
(	NULL
16	NULL
)	NULL
.	NULL

Bright	NULL
binds	NULL
within	NULL
the	NULL
MARs	NULL
of	NULL
the	NULL
IgH	NULL
enhancer	NULL
to	NULL
distinct	NULL
ATC	NULL
motifs	NULL
(	NULL
P	NULL
sites	NULL
)	NULL
previously	NULL
identified	NULL
as	NULL
binding	NULL
sites	NULL
for	NULL
the	NULL
Ep	NULL
negative	NULL
regulator	NULL
,	NULL
nuclear	NULL
factor-u	NULL
negative	NULL
regulator	NULL
,	NULL
and	NULL
the	NULL
MAR-binding	NULL
protein	NULL
,	NULL
SATB1	NULL
(	NULL
11	NULL
,	NULL
17	NULL
)	NULL
.	NULL

We	NULL
have	NULL
identified	NULL
nuclear	NULL
factor-u	NULL
negative	NULL
regulator	NULL
as	NULL
a	NULL
previously	NULL
characterized	NULL
,	NULL
lineage-non-restricted	NULL
homeoprotein	NULL
,	NULL
Cux/CAAT	NULL
displacement	NULL
protein	NULL
(	NULL
18	NULL
)	NULL
,	NULL
that	NULL
antagonizes	NULL
Bright	NULL
binding	NULL
and	NULL
transactivation	NULL
by	NULL
direct	NULL
competition	NULL
for	NULL
P	NULL
sites	NULL
.	NULL

Developmentally	NULL
,	NULL
Bright	NULL
expression	NULL
is	NULL
maximal	NULL
in	NULL
late	NULL
stage	NULL
B	NULL
cells	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
,	NULL
a	NULL
pattern	NULL
opposite	NULL
that	NULL
of	NULL
Cux/CAAT	NULL
displacement	NULL
protein	NULL
(	NULL
18	NULL
)	NULL
.	NULL

Bright	NULL
is	NULL
found	NULL
in	NULL
the	NULL
nuclear	NULL
matrix	NULL
and	NULL
within	NULL
matrix-associated	NULL
PML	NULL
nuclear	NULL
bodies	NULL
(	NULL
13	NULL
,	NULL
20	NULL
)	NULL
,	NULL
locations	NULL
consistent	NULL
with	NULL
a	NULL
putative	NULL
role	NULL
in	NULL
chromosomal	NULL
organization	NULL
.	NULL

Although	NULL
a	NULL
number	NULL
of	NULL
MAR	NULL
binding	NULL
factors	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
e.g	NULL
.	NULL

see	NULL
Refs	NULL
.	NULL

13	NULL
,	NULL
17	NULL
,	NULL
and	NULL
21-29	NULL
,	NULL
and	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

30	NULL
)	NULL
,	NULL
Bright	NULL
was	NULL
the	NULL
first	NULL
shown	NULL
to	NULL
directly	NULL
affect	NULL
gene	NULL
transcription	NULL
.	NULL

MARs	NULL
and	NULL
attachment	NULL
to	NULL
the	NULL
nuclear	NULL
matrix	NULL
can	NULL
mediate	NULL
specific	NULL
alterations	NULL
in	NULL
chromatin	NULL
structure	NULL
(	NULL
31-34	NULL
)	NULL
.	NULL

Such	NULL
a	NULL
mechanism	NULL
seemed	NULL
reasonable	NULL
for	NULL
Bright	NULL
,	NULL
based	NULL
on	NULL
features	NULL
of	NULL
its	NULL
DNA	NULL
binding	NULL
.	NULL

Highly	NULL
specific	NULL
binding	NULL
within	NULL
the	NULL
minor	NULL
groove	NULL
is	NULL
achieved	NULL
by	NULL
virtue	NULL
of	NULL
two	NULL
domains	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

21325	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
21326	NULL
35	NULL
)	NULL
,	NULL
a	NULL
self-association/tetramerization	NULL
domain	NULL
,	NULL
termed	NULL
REKLES	NULL
for	NULL
a	NULL
heptapeptide	NULL
conserved	NULL
within	NULL
this	NULL
region	NULL
among	NULL
Bright	NULL
orthologues	NULL
,	NULL
and	NULL
a	NULL
DNA	NULL
binding	NULL
region	NULL
,	NULL
termed	NULL
ARID	NULL
for	NULL
AT-rich	NULL
interaction	NULL
domain	NULL
.	NULL

The	NULL
Bright	NULL
ARID	NULL
defined	NULL
a	NULL
new	NULL
family	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
,	NULL
including	NULL
SW1I1	NULL
,	NULL
a	NULL
component	NULL
of	NULL
the	NULL
SWI-SNF	NULL
complex	NULL
that	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
remodel	NULL
chromatin	NULL
(	NULL
86	NULL
)	NULL
and	NULL
p270	NULL
,	NULL
its	NULL
apparent	NULL
mammalian	NULL
orthologue	NULL
(	NULL
37	NULL
)	NULL
.	NULL

Components	NULL
of	NULL
human	NULL
SWI-SNF	NULL
appear	NULL
to	NULL
be	NULL
tightly	NULL
associated	NULL
with	NULL
the	NULL
nuclear	NULL
matrix	NULL
(	NULL
38	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
at	NULL
least	NULL
a	NULL
fraction	NULL
of	NULL
this	NULL
complex	NULL
could	NULL
be	NULL
involved	NULL
in	NULL
chromatin	NULL
organizational	NULL
properties	NULL
associated	NULL
with	NULL
MARs	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

39	NULL
)	NULL
.	NULL

Like	NULL
SWI-SNF	NULL
,	NULL
all	NULL
ARID	NULL
proteins	NULL
bind	NULL
AT-rich	NULL
DNA	NULL
,	NULL
but	NULL
only	NULL
members	NULL
that	NULL
contain	NULL
both	NULL
ARID	NULL
and	NULL
REKLES	NULL
bind	NULL
specifically	NULL
to	NULL
AT-rich	NULL
MAR	NULL
motifs	NULL
(	NULL
85	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
further	NULL
characterize	NULL
the	NULL
mechanisms	NULL
through	NULL
which	NULL
Bright	NULL
functions	NULL
and	NULL
the	NULL
contextual	NULL
requirements	NULL
for	NULL
Bright	NULL
transactivation	NULL
.	NULL

We	NULL
also	NULL
show	NULL
that	NULL
Bright	NULL
bends	NULL
its	NULL
DNA	NULL
target	NULL
on	NULL
binding	NULL
.	NULL

This	NULL
,	NULL
along	NULL
with	NULL
the	NULL
observation	NULL
that	NULL
Bright	NULL
overexpression	NULL
induces	NULL
increased	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
of	NULL
the	NULL
enhancer	NULL
,	NULL
provides	NULL
a	NULL
rationale	NULL
for	NULL
how	NULL
this	NULL
protein	NULL
may	NULL
facilitate	NULL
enhanced	NULL
expression	NULL
of	NULL
the	NULL
immunoglobulin	NULL
gene	NULL
.	NULL

EXPERIMENTAL	NULL
PROCEDURES	NULL
Constructs-The	NULL
derivation	NULL
of	NULL
AEu	NULL
and	NULL
AP	NULL
Ep	NULL
mutants	NULL
was	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Ep	NULL
and	NULL
AEp	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
Xbal	NULL
site	NULL
of	NULL
the	NULL
pBL-CAT2	NULL
vector	NULL
.	NULL

All	NULL
AP	NULL
mutants	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
Safl-BamHI	NULL
sites	NULL
of	NULL
the	NULL
CAT	NULL
vector	NULL
.	NULL

The	NULL
hybrid	NULL
SV4A0-MAR	NULL
construct	NULL
(	NULL
40	NULL
)	NULL
was	NULL
previously	NULL
constructed	NULL
.	NULL

The	NULL
S107	NULL
promoter	NULL
was	NULL
isolated	NULL
as	NULL
a	NULL
BamHI-HaellI	NULL
fragment	NULL
(	NULL
covering	NULL
nucleotides	NULL
-550	NULL
to	NULL
-40	NULL
)	NULL
,	NULL
blunt-ended	NULL
,	NULL
and	NULL
cloned	NULL
into	NULL
the	NULL
pBL-CAT2	NULL
vector	NULL
.	NULL

Vectors	NULL
containing	NULL
elements	NULL
distal	NULL
of	NULL
the	NULL
cat	NULL
gene	NULL
were	NULL
constructed	NULL
by	NULL
first	NULL
subcloning	NULL
Ep	NULL
of	NULL
the	NULL
appropriate	NULL
mutation	NULL
into	NULL
pBluescript	NULL
(	NULL
Stratagene	NULL
)	NULL
and	NULL
cloning	NULL
a	NULL
KprI-Sacl	NULL
fragment	NULL
into	NULL
the	NULL
distal	NULL
site	NULL
of	NULL
either	NULL
pBL-CAT2	NULL
or	NULL
pBL-CAT2	NULL
containing	NULL
the	NULL
S107	NULL
promoter	NULL
fragment	NULL
.	NULL

Electrophoretic	NULL
Mobility	NULL
Shift	NULL
Assay-Specifics	NULL
of	NULL
binding	NULL
reactions	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

To	NULL
assess	NULL
binding	NULL
to	NULL
the	NULL
four	NULL
P	NULL
sites	NULL
,	NULL
the	NULL
following	NULL
contructs	NULL
were	NULL
used	NULL
:	NULL
the	NULL
AP2	NULL
Ep	NULL
5	NULL
'	NULL
MAR	NULL
isolates	NULL
the	NULL
P1	NULL
site	NULL
,	NULL
the	NULL
AP1	NULL
Eu	NULL
5°	NULL
MAR	NULL
isolates	NULL
the	NULL
P2	NULL
site	NULL
,	NULL
the	NULL
AP4	NULL
Eu	NULL
3	NULL
``	NULL
MAR	NULL
isolates	NULL
the	NULL
P3	NULL
site	NULL
,	NULL
and	NULL
the	NULL
AP3	NULL
Ep	NULL
3	NULL
'	NULL
MAR	NULL
isolates	NULL
the	NULL
P4	NULL
site	NULL
.	NULL

Briefly	NULL
,	NULL
these	NULL
fragments	NULL
were	NULL
end-labeled	NULL
(	NULL
20,000	NULL
epm/fmol	NULL
)	NULL
,	NULL
bound	NULL
to	NULL
in	NULL
vitro-translated	NULL
Bright	NULL
protein	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
poly	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
,	NULL
and	NULL
run	NULL
on	NULL
a	NULL
4	NULL
%	NULL
nondenaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
to	NULL
x-ray	NULL
film	NULL
.	NULL

Transfections	NULL
and	NULL
Stable	NULL
Lines-Transfections	NULL
of	NULL
M12.4	NULL
and	NULL
J558L	NULL
cells	NULL
and	NULL
analysis	NULL
of	NULL
CAT	NULL
protein	NULL
was	NULL
done	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Stable	NULL
transfectant	NULL
lines	NULL
were	NULL
made	NULL
by	NULL
co-transfecting	NULL
the	NULL
indicated	NULL
CAT	NULL
vector	NULL
in	NULL
a	NULL
3-fold	NULL
excess	NULL
to	NULL
pBK-cytomegalovirus	NULL
(	NULL
Stratagene	NULL
)	NULL
.	NULL

48	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
selected	NULL
in	NULL
G418	NULL
.	NULL

Transient	NULL
transfection	NULL
of	NULL
these	NULL
cell	NULL
with	NULL
the	NULL
Bright	NULL
sense	NULL
or	NULL
antisense	NULL
constructs	NULL
were	NULL
done	NULL
3-5	NULL
weeks	NULL
after	NULL
the	NULL
selection	NULL
began	NULL
.	NULL

Circular	NULL
Permutation	NULL
Distortion	NULL
Assays-The	NULL
high	NULL
affinity	NULL
Bright	NULL
binding	NULL
site	NULL
(	NULL
P2	NULL
X	NULL
3	NULL
)	NULL
and	NULL
the	NULL
circular	NULL
permutation	NULL
plasmid	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
,	NULL
41	NULL
)	NULL
.	NULL

The	NULL
P2	NULL
site	NULL
concatamer	NULL
was	NULL
cloned	NULL
into	NULL
the	NULL
plasmid	NULL
polylinker	NULL
and	NULL
confirmed	NULL
by	NULL
sequencing	NULL
.	NULL

A	NULL
second	NULL
series	NULL
utilized	NULL
an	NULL
~500-bp	NULL
fragment	NULL
spanning	NULL
the	NULL
core	NULL
octamer	NULL
and	NULL
3	NULL
``	NULL
MAR	NULL
P3	NULL
site	NULL
of	NULL
Eu	NULL
.	NULL

Circular	NULL
permutated	NULL
fragments	NULL
were	NULL
generated	NULL
by	NULL
appropriate	NULL
restriction	NULL
digests	NULL
.	NULL

Mobility	NULL
shift	NULL
assay	NULL
with	NULL
these	NULL
fragments	NULL
and	NULL
in	NULL
vitro-translated	NULL
full-length	NULL
or	NULL
truncated	NULL
(	NULL
amino	NULL
acids	NULL
216-601	NULL
)	NULL
Bright	NULL
protein	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
binding	NULL
and	NULL
functional	NULL
activity	NULL
of	NULL
the	NULL
truncated	NULL
Bright	NULL
polypeptide	NULL
were	NULL
described	NULL
previously	NULL
(	NULL
22	NULL
)	NULL
.	NULL

The	NULL
distortion	NULL
angle	NULL
was	NULL
estimated	NULL
by	NULL
the	NULL
method	NULL
of	NULL
Thompson	NULL
and	NULL
Landy	NULL
(	NULL
42	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
the	NULL
relative	NULL
mobilities	NULL
of	NULL
the	NULL
fastest	NULL
complex	NULL
(	NULL
uF	NULL
)	NULL
and	NULL
the	NULL
slowest	NULL
complex	NULL
(	NULL
uM	NULL
)	NULL
are	NULL
determined	NULL
.	NULL

This	NULL
ratio	NULL
is	NULL
then	NULL
plotted	NULL
on	NULL
a	NULL
graph	NULL
of	NULL
wM/uE	NULL
(	NULL
abscissa	NULL
)	NULL
and	NULL
distortion	NULL
angle	NULL
(	NULL
ordinate	NULL
)	NULL
derived	NULL
from	NULL
A-tract	NULL
standards	NULL
.	NULL

DNase	NULL
I	NULL
Digestion	NULL
of	NULL
Isolated	NULL
Nuclei	NULL
and	NULL
Hypersensitive	NULL
Site	NULL
Analy-sis-Nuclei	NULL
were	NULL
isolated	NULL
and	NULL
treated	NULL
with	NULL
DNase	NULL
I	NULL
as	NULL
detailed	NULL
previously	NULL
(	NULL
48	NULL
)	NULL
.	NULL

Nuclease	NULL
digests	NULL
were	NULL
restricted	NULL
with	NULL
Bg/II	NULL
and	NULL
analyzed	NULL
on	NULL
a	NULL
1.4	NULL
%	NULL
agarose	NULL
gel	NULL
in	NULL
1	NULL
X	NULL
TAE	NULL
(	NULL
40	NULL
mM	NULL
Tris	NULL
acetate	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
blotted	NULL
onto	NULL
a	NULL
Bio-Rad	NULL
Zeta	NULL
probe	NULL
nylon	NULL
membrane	NULL
by	NULL
a	NULL
modified	NULL
alkaline	NULL
blotting	NULL
protocol	NULL
(	NULL
48	NULL
)	NULL
.	NULL

The	NULL
gel	NULL
was	NULL
blotted	NULL
overnight	NULL
in	NULL
0.4	NULL
M	NULL
NaOH	NULL
,	NULL
0.2	NULL
M	NULL
NaCl	NULL
.	NULL

The	NULL
membrane	NULL
was	NULL
then	NULL
neutralized	NULL
in	NULL
50	NULL
mM	NULL
Tris	NULL
at	NULL
pH	NULL
7.5	NULL
for	NULL
5	NULL
to	NULL
10	NULL
min	NULL
,	NULL
air	NULL
dried	NULL
,	NULL
and	NULL
baked	NULL
at	NULL
80	NULL
°C	NULL
under	NULL
Contextual	NULL
Requirements	NULL
for	NULL
the	NULL
Function	NULL
of	NULL
Bright	NULL
Vector	NULL
-	NULL
Cell	NULL
Line	NULL
Bfi50x8	NULL
1558	NULL
P2x3	NULL
1558	NULL
Px3	NULL
-	NULL
MI24	NULL
0	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fold	NULL
transactivation	NULL
Fic	NULL
.	NULL

1	NULL
.	NULL

Bright	NULL
does	NULL
not	NULL
transactivate	NULL
from	NULL
a	NULL
concatamerized	NULL
binding	NULL
site	NULL
.	NULL

M12.4	NULL
or	NULL
J558L	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
tk-CAT	NULL
vectors	NULL
containing	NULL
concatamers	NULL
of	NULL
the	NULL
Eu	NULL
P2	NULL
site	NULL
or	NULL
of	NULL
the	NULL
high	NULL
affinity	NULL
Bf150	NULL
site	NULL
from	NULL
the	NULL
S107	NULL
promoter	NULL
as	NULL
indicated	NULL
.	NULL

Cells	NULL
were	NULL
co-transfected	NULL
with	NULL
an	NULL
expression	NULL
vector	NULL
containing	NULL
Bright	NULL
in	NULL
the	NULL
sense	NULL
(	NULL
filled	NULL
bars	NULL
)	NULL
or	NULL
antisense	NULL
(	NULL
open	NULL
bars	NULL
)	NULL
orientation	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
-fold	NULL
activation	NULL
over	NULL
tk-CAT	NULL
alone	NULL
and	NULL
are	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
four	NULL
separate	NULL
experiments	NULL
.	NULL

a	NULL
vacuum	NULL
for	NULL
1	NULL
h.	NULL
Prehybridization	NULL
was	NULL
carried	NULL
out	NULL
from	NULL
2	NULL
h	NULL
to	NULL
overnight	NULL
in	NULL
0.27	NULL
M	NULL
NaCl	NULL
,	NULL
15	NULL
mM	NULL
sodium	NULL
phosphate	NULL
(	NULL
pH	NULL
7.0	NULL
)	NULL
,	NULL
1.5	NULL
mm	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
BLOTTO	NULL
dried	NULL
milk	NULL
powder	NULL
,	NULL
1	NULL
%	NULL
SDS	NULL
,	NULL
500	NULL
ug	NULL
of	NULL
sonicated	NULL
herring	NULL
testis	NULL
DNA	NULL
per	NULL
ml	NULL
.	NULL

Hybridization	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
in	NULL
the	NULL
same	NULL
buffer	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
at	NULL
least	NULL
2.5	NULL
X	NULL
10	NULL
``	NULL
cpm	NULL
of	NULL
a	NULL
radiolabeled	NULL
DNA	NULL
probe	NULL
(	NULL
specific	NULL
activity	NULL
,	NULL
at	NULL
least	NULL
10°	NULL
cpm/ug	NULL
)	NULL
generated	NULL
by	NULL
random	NULL
primer	NULL
synthesis	NULL
with	NULL
a	NULL
Decaprime	NULL
DNA	NULL
labeling	NULL
kit	NULL
(	NULL
Ambion	NULL
,	NULL
Austin	NULL
,	NULL
TX	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
probe	NULL
used	NULL
was	NULL
a	NULL
800-bp	NULL
Xbal-EcoRI	NULL
restriction	NULL
fragment	NULL
found	NULL
just	NULL
downstream	NULL
of	NULL
the	NULL
Ep	NULL
3	NULL
``	NULL
MAR	NULL
(	NULL
44	NULL
)	NULL
.	NULL

Autoradiograms	NULL
were	NULL
calibrated	NULL
with	NULL
DNA	NULL
standards	NULL
2.3	NULL
,	NULL
2.0	NULL
,	NULL
1.3	NULL
,	NULL
1.1	NULL
,	NULL
and	NULL
0.87-kb-long	NULL
by	NULL
constructing	NULL
a	NULL
plot	NULL
of	NULL
log	NULL
DNA	NULL
size	NULL
versus	NULL
mobility	NULL
.	NULL

The	NULL
sizes	NULL
of	NULL
the	NULL
resulting	NULL
hypersensitive	NULL
fragments	NULL
were	NULL
interpolated	NULL
from	NULL
the	NULL
resulting	NULL
linear	NULL
fit	NULL
.	NULL

RESULTS	NULL
Bright	NULL
Does	NULL
Not	NULL
Transactivate	NULL
from	NULL
a	NULL
Concatamerized	NULL
Binding	NULL
Site-In	NULL
our	NULL
first	NULL
description	NULL
of	NULL
the	NULL
Bright	NULL
transcription	NULL
factor	NULL
(	NULL
13	NULL
)	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
Bright	NULL
could	NULL
transactivate	NULL
gene	NULL
expression	NULL
from	NULL
a	NULL
plasmid	NULL
containing	NULL
an	NULL
IgH	NULL
enhancer	NULL
element	NULL
(	NULL
Ep	NULL
)	NULL
upstream	NULL
of	NULL
a	NULL
reporter	NULL
gene	NULL
.	NULL

To	NULL
assess	NULL
the	NULL
ability	NULL
of	NULL
Bright	NULL
to	NULL
transactivate	NULL
gene	NULL
expression	NULL
from	NULL
a	NULL
binding	NULL
site	NULL
not	NULL
in	NULL
context	NULL
of	NULL
the	NULL
Eu	NULL
enhancer	NULL
,	NULL
we	NULL
used	NULL
reporter	NULL
constructs	NULL
containing	NULL
concatamers	NULL
of	NULL
a	NULL
binding	NULL
site	NULL
in	NULL
the	NULL
S107	NULL
promoter	NULL
(	NULL
Bf150	NULL
)	NULL
or	NULL
the	NULL
Ep	NULL
P2	NULL
site	NULL
in	NULL
transient	NULL
transfections	NULL
.	NULL

Expression	NULL
constructs	NULL
containing	NULL
Bright	NULL
in	NULL
either	NULL
the	NULL
sense	NULL
or	NULL
antisense	NULL
orientation	NULL
were	NULL
co-transfected	NULL
with	NULL
reporter	NULL
constructs	NULL
driven	NULL
by	NULL
a	NULL
thymidine	NULL
kinase	NULL
promoter	NULL
and	NULL
the	NULL
additional	NULL
elements	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Concatamers	NULL
of	NULL
the	NULL
P2	NULL
site	NULL
,	NULL
which	NULL
gel	NULL
shift	NULL
analysis	NULL
demonstrated	NULL
is	NULL
a	NULL
strong	NULL
Bright	NULL
binding	NULL
site	NULL
,	NULL
could	NULL
not	NULL
increase	NULL
CAT	NULL
levels	NULL
in	NULL
either	NULL
a	NULL
B	NULL
cell	NULL
or	NULL
plasma	NULL
cell	NULL
line	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Similarly	NULL
,	NULL
a	NULL
reporter	NULL
construct	NULL
with	NULL
the	NULL
S107	NULL
MAR	NULL
site	NULL
concatamerized	NULL
to	NULL
eight	NULL
repeats	NULL
(	NULL
Bf150	NULL
X	NULL
8	NULL
)	NULL
did	NULL
not	NULL
show	NULL
any	NULL
significant	NULL
increase	NULL
in	NULL
transcription	NULL
when	NULL
Bright	NULL
was	NULL
co-transfected	NULL
in	NULL
the	NULL
sense	NULL
orientation	NULL
.	NULL

Bright	NULL
Requires	NULL
Specific	NULL
MAR	NULL
Sequences	NULL
for	NULL
Transactivation	NULL
Function-Despite	NULL
the	NULL
lack	NULL
of	NULL
Bright	NULL
activity	NULL
on	NULL
a	NULL
concatamerized	NULL
substrate	NULL
,	NULL
Bright	NULL
clearly	NULL
activated	NULL
transcription	NULL
from	NULL
an	NULL
Ep	NULL
element	NULL
over	NULL
the	NULL
levels	NULL
seen	NULL
from	NULL
Ep	NULL
alone	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

13	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Bright	NULL
binding	NULL
sites	NULL
were	NULL
required	NULL
for	NULL
this	NULL
activity	NULL
,	NULL
because	NULL
an	NULL
Ep	NULL
that	NULL
lacked	NULL
the	NULL
P	NULL
sites	NULL
(	NULL
AEp	NULL
)	NULL
did	NULL
not	NULL
mediate	NULL
Bright	NULL
transactivation	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

13	NULL
and	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

To	NULL
further	NULL
examine	NULL
the	NULL
specificity	NULL
for	NULL
transactivation	NULL
that	NULL
Eu	NULL
ascribes	NULL
to	NULL
Bright	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
P	NULL
site	NULL
deletions	NULL
.	NULL

Because	NULL
P2	NULL
is	NULL
a	NULL
well	NULL
characterized	NULL
Bright	NULL
binding	NULL
site	NULL
(	NULL
13	NULL
)	NULL
,	NULL
we	NULL
reasoned	NULL
that	NULL
it	NULL
might	NULL
be	NULL
capable	NULL
of	NULL
acting	NULL
alone	NULL
.	NULL

Indeed	NULL
,	NULL
a	NULL
construct	NULL
that	NULL
lacks	NULL
P1	NULL
,	NULL
P3	NULL
,	NULL
and	NULL
P4	NULL
(	NULL
AP1	NULL
,	NULL
P3	NULL
,	NULL
P4	NULL
)	NULL
was	NULL
competent	NULL
in	NULL
mediating	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Contextual	NULL
Requirements	NULL
for	NULL
the	NULL
Function	NULL
of	NULL
Bright	NULL
s	NULL
'	NULL
MAR	NULL
_	NULL
core	NULL
3°	NULL
MAR	NULL
Eu	NULL
PI	NULL
Pr	NULL
ps	NULL
4	NULL
AP1	NULL
,	NULL
P3	NULL
,	NULL
P4	NULL
[	NULL
IE	NULL
]	NULL
AP2	NULL
I	NULL
|	NULL
|II	NULL
sevezes	NULL
[	NULL
|	NULL
--	NULL
-|	NULL
|	NULL
]	NULL
Io	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
Fold	NULL
Activation	NULL
Fic	NULL
.	NULL

2	NULL
.	NULL

Bright	NULL
requires	NULL
specific	NULL
Ep	NULL
P	NULL
sites	NULL
for	NULL
function	NULL
.	NULL

J558L	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
tk-CAT	NULL
vectors	NULL
containing	NULL
wild-type	NULL
or	NULL
mutant	NULL
Ep	NULL
elements	NULL
upstream	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
as	NULL
indicated	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
-fold	NULL
transactivation	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
Bright	NULL
sense	NULL
construct	NULL
over	NULL
transfections	NULL
with	NULL
the	NULL
antisense	NULL
construct	NULL
.	NULL

Ep	NULL
alone	NULL
conferred	NULL
a	NULL
10-20-fold	NULL
increase	NULL
in	NULL
CAT	NULL
over	NULL
tk-CAT	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Bright	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
average	NULL
of	NULL
at	NULL
least	NULL
four	NULL
separate	NULL
transfections	NULL
.	NULL

Bright	NULL
transactivation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

However	NULL
,	NULL
a	NULL
construct	NULL
that	NULL
lacked	NULL
the	NULL
P2	NULL
but	NULL
had	NULL
all	NULL
other	NULL
sites	NULL
intact	NULL
(	NULL
AP2	NULL
)	NULL
was	NULL
still	NULL
functional	NULL
.	NULL

The	NULL
additional	NULL
deletion	NULL
of	NULL
the	NULL
P4	NULL
site	NULL
(	NULL
AP2	NULL
,	NULL
P4	NULL
)	NULL
abrogated	NULL
Bright-	NULL
mediated	NULL
function	NULL
.	NULL

That	NULL
P4	NULL
could	NULL
mediate	NULL
Bright	NULL
transactivation	NULL
alone	NULL
was	NULL
verified	NULL
using	NULL
a	NULL
P4-only	NULL
construct	NULL
(	NULL
AP1	NULL
,	NULL
P2	NULL
,	NULL
P3	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
there	NULL
was	NULL
a	NULL
trend	NULL
that	NULL
the	NULL
P2-only	NULL
and	NULL
P4-only	NULL
constructs	NULL
were	NULL
activated	NULL
to	NULL
a	NULL
slightly	NULL
lower	NULL
degree	NULL
than	NULL
the	NULL
intact	NULL
Ep	NULL
,	NULL
though	NULL
the	NULL
difference	NULL
was	NULL
not	NULL
statistically	NULL
significant	NULL
.	NULL

It	NULL
seems	NULL
possible	NULL
that	NULL
Bright	NULL
can	NULL
act	NULL
through	NULL
both	NULL
sites	NULL
but	NULL
that	NULL
the	NULL
activity	NULL
seen	NULL
in	NULL
the	NULL
intact	NULL
Ep	NULL
may	NULL
be	NULL
the	NULL
combined	NULL
effects	NULL
of	NULL
Bright	NULL
binding	NULL
to	NULL
both	NULL
sites	NULL
.	NULL

It	NULL
was	NULL
unanticipated	NULL
that	NULL
Bright	NULL
could	NULL
not	NULL
function	NULL
through	NULL
the	NULL
P3	NULL
site	NULL
,	NULL
because	NULL
Bright	NULL
also	NULL
binds	NULL
P3	NULL
very	NULL
well	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

This	NULL
lack	NULL
of	NULL
function	NULL
suggested	NULL
that	NULL
competent	NULL
Bright	NULL
binding	NULL
sites	NULL
must	NULL
be	NULL
within	NULL
a	NULL
contextual	NULL
arrangement	NULL
to	NULL
allow	NULL
them	NULL
to	NULL
mediate	NULL
transactivation	NULL
.	NULL

Bright	NULL
Mediates	NULL
Promoter-Enhancer	NULL
Interactions-Knowing	NULL
that	NULL
Bright	NULL
could	NULL
mediate	NULL
transactivation	NULL
from	NULL
both	NULL
the	NULL
enhancer	NULL
and	NULL
the	NULL
S107	NULL
promoter	NULL
(	NULL
and	NULL
possibly	NULL
other	NULL
Ig	NULL
promot-ers	NULL
,	NULL
as	NULL
well	NULL
)	NULL
,	NULL
we	NULL
became	NULL
interested	NULL
in	NULL
determining	NULL
whether	NULL
these	NULL
functions	NULL
were	NULL
independent	NULL
or	NULL
whether	NULL
these	NULL
elements	NULL
could	NULL
function	NULL
in	NULL
concert	NULL
.	NULL

We	NULL
constructed	NULL
CAT	NULL
vectors	NULL
that	NULL
partially	NULL
or	NULL
completely	NULL
recapitulated	NULL
the	NULL
immunoglobulin	NULL
locus	NULL
promoter/enhancer	NULL
arrangement	NULL
.	NULL

The	NULL
S107	NULL
promoter	NULL
fragment	NULL
contains	NULL
two	NULL
Bright	NULL
binding	NULL
sites	NULL
,	NULL
one	NULL
of	NULL
which	NULL
functions	NULL
as	NULL
a	NULL
MAR	NULL
(	NULL
15	NULL
,	NULL
45	NULL
)	NULL
.	NULL

In	NULL
a	NULL
construct	NULL
containing	NULL
the	NULL
promoter	NULL
alone	NULL
,	NULL
Bright	NULL
could	NULL
not	NULL
transactivate	NULL
in	NULL
a	NULL
transient	NULL
assay	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
assays	NULL
where	NULL
Ep	NULL
is	NULL
placed	NULL
5	NULL
'	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
and	NULL
Bright	NULL
effectively	NULL
increased	NULL
gene	NULL
expression	NULL
.	NULL

The	NULL
ability	NULL
of	NULL
Bright	NULL
to	NULL
function	NULL
through	NULL
the	NULL
IgH	NULL
enhancer	NULL
is	NULL
also	NULL
seen	NULL
when	NULL
the	NULL
enhancer	NULL
is	NULL
in	NULL
the	NULL
distal	NULL
position	NULL
.	NULL

Strikingly	NULL
,	NULL
when	NULL
both	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
are	NULL
present	NULL
in	NULL
the	NULL
same	NULL
construct	NULL
,	NULL
the	NULL
effects	NULL
of	NULL
Bright	NULL
are	NULL
synergistic	NULL
,	NULL
increasing	NULL
transcription	NULL
levels	NULL
more	NULL
than	NULL
3-fold	NULL
over	NULL
that	NULL
seen	NULL
with	NULL
Ep	NULL
alone	NULL
in	NULL
the	NULL
distal	NULL
position	NULL
.	NULL

This	NULL
Bright-mediated	NULL
transactivation	NULL
requires	NULL
Bright	NULL
binding	NULL
,	NULL
because	NULL
a	NULL
construct	NULL
with	NULL
AEp	NULL
in	NULL
the	NULL
distal	NULL
position	NULL
could	NULL
not	NULL
mediate	NULL
the	NULL
Bright	NULL
effect	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Bright	NULL
Transactivates	NULL
Integrated	NULL
Targets	NULL
by	NULL
MAR	NULL
Interac-tion-Because	NULL
Bright	NULL
binding	NULL
sites	NULL
have	NULL
the	NULL
potential	NULL
to	NULL
act	NULL
as	NULL
MARs	NULL
,	NULL
we	NULL
also	NULL
studied	NULL
these	NULL
vectors	NULL
in	NULL
stably	NULL
transfected	NULL
cells	NULL
to	NULL
determine	NULL
whether	NULL
Bright	NULL
can	NULL
mediate	NULL
MAR	NULL
effects	NULL
that	NULL
21327	NULL
would	NULL
only	NULL
be	NULL
detected	NULL
from	NULL
integrated	NULL
targets	NULL
.	NULL

CAT	NULL
constructs	NULL
were	NULL
stably	NULL
transfected	NULL
into	NULL
J558L	NULL
cells	NULL
and	NULL
selected	NULL
with	NULL
neomycin	NULL
for	NULL
21	NULL
days	NULL
before	NULL
transient	NULL
transfection	NULL
with	NULL
Bright	NULL
sense	NULL
or	NULL
antisense	NULL
constructs	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
results	NULL
from	NULL
the	NULL
transient	NULL
transfection	NULL
assay	NULL
,	NULL
Bright	NULL
is	NULL
able	NULL
to	NULL
transactivate	NULL
from	NULL
the	NULL
promoter	NULL
alone	NULL
in	NULL
the	NULL
stable	NULL
system	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

This	NULL
supports	NULL
a	NULL
role	NULL
for	NULL
Bright	NULL
as	NULL
a	NULL
MAR-binding	NULL
protein	NULL
,	NULL
because	NULL
this	NULL
phenomenon	NULL
is	NULL
only	NULL
seen	NULL
when	NULL
the	NULL
promoter	NULL
construct	NULL
is	NULL
integrated	NULL
into	NULL
the	NULL
chromosome	NULL
.	NULL

A	NULL
further	NULL
increase	NULL
in	NULL
S107	NULL
promoter-driven	NULL
transcription	NULL
is	NULL
seen	NULL
when	NULL
Ep	NULL
is	NULL
present	NULL
in	NULL
the	NULL
distal	NULL
position	NULL
.	NULL

As	NULL
in	NULL
the	NULL
transient	NULL
studies	NULL
,	NULL
this	NULL
interaction	NULL
is	NULL
specific	NULL
for	NULL
Bright	NULL
binding	NULL
,	NULL
because	NULL
a	NULL
construct	NULL
with	NULL
AEu	NULL
in	NULL
the	NULL
distal	NULL
position	NULL
does	NULL
not	NULL
transactivate	NULL
beyond	NULL
what	NULL
is	NULL
seen	NULL
with	NULL
promoter	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Bright	NULL
Mediates	NULL
DNA	NULL
Distortion-The	NULL
distance	NULL
between	NULL
pro-moter-associated	NULL
and	NULL
enhancer-associated	NULL
Bright	NULL
sites	NULL
that	NULL
appear	NULL
to	NULL
synergize	NULL
in	NULL
the	NULL
constructs	NULL
of	NULL
Fig	NULL
.	NULL

4	NULL
is	NULL
about	NULL
2	NULL
kilobase	NULL
pairs	NULL
.	NULL

We	NULL
assumed	NULL
that	NULL
Bright	NULL
may	NULL
affect	NULL
DNA	NULL
topology	NULL
to	NULL
facilitate	NULL
these	NULL
interactions	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
Bright	NULL
binds	NULL
DNA	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
class	NULL
of	NULL
high	NULL
mobility	NULL
group	NULL
box	NULL
proteins	NULL
typified	NULL
by	NULL
lymphoid	NULL
enhancer-binding	NULL
factor-1	NULL
and	NULL
SRY	NULL
bind	NULL
DNA	NULL
in	NULL
the	NULL
minor	NULL
groove	NULL
and	NULL
bend	NULL
the	NULL
double	NULL
helix	NULL
(	NULL
41	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
Bright	NULL
can	NULL
also	NULL
distort	NULL
its	NULL
DNA	NULL
target	NULL
on	NULL
binding	NULL
,	NULL
we	NULL
used	NULL
the	NULL
circular	NULL
permutation	NULL
assay	NULL
described	NULL
by	NULL
Giese	NULL
et	NULL
al	NULL
.	NULL

(	NULL
41	NULL
)	NULL
,	NULL
which	NULL
measures	NULL
DNA	NULL
bending	NULL
,	NULL
as	NULL
well	NULL
as	NULL
DNA	NULL
flexibility	NULL
caused	NULL
by	NULL
changes	NULL
in	NULL
DNA	NULL
structure	NULL
such	NULL
as	NULL
melting	NULL
of	NULL
AT-rich	NULL
regions	NULL
.	NULL

For	NULL
this	NULL
assay	NULL
,	NULL
a	NULL
series	NULL
of	NULL
equally	NULL
sized	NULL
fragments	NULL
,	NULL
differing	NULL
only	NULL
in	NULL
the	NULL
position	NULL
of	NULL
a	NULL
Bright	NULL
binding	NULL
site	NULL
,	NULL
were	NULL
generated	NULL
.	NULL

If	NULL
the	NULL
DNA	NULL
is	NULL
distorted	NULL
during	NULL
binding	NULL
,	NULL
then	NULL
fragments	NULL
bound	NULL
near	NULL
the	NULL
center	NULL
will	NULL
migrate	NULL
through	NULL
a	NULL
gel	NULL
at	NULL
a	NULL
slower	NULL
rate	NULL
than	NULL
those	NULL
bound	NULL
near	NULL
the	NULL
ends	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
a	NULL
truncated	NULL
Bright	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
216-601	NULL
)	NULL
with	NULL
full	NULL
binding	NULL
activity	NULL
distorts	NULL
the	NULL
circular	NULL
permutated	NULL
fragments	NULL
as	NULL
assessed	NULL
by	NULL
differences	NULL
in	NULL
complex	NULL
mobility	NULL
.	NULL

The	NULL
full-length	NULL
Bright	NULL
protein	NULL
had	NULL
an	NULL
identical	NULL
effect	NULL
in	NULL
this	NULL
assay	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
angle	NULL
of	NULL
induced	NULL
distortion	NULL
can	NULL
be	NULL
determined	NULL
by	NULL
comparing	NULL
the	NULL
calculated	NULL
ratio	NULL
uM/uE	NULL
to	NULL
a	NULL
plot	NULL
of	NULL
known	NULL
A-tract	NULL
standards	NULL
,	NULL
where	NULL
uM	NULL
and	NULL
uF	NULL
are	NULL
the	NULL
relative	NULL
mobilities	NULL
of	NULL
the	NULL
middle-bound	NULL
(	NULL
slowest	NULL
migrating	NULL
)	NULL
and	NULL
end-bound	NULL
(	NULL
fastest	NULL
migrating	NULL
)	NULL
fragments	NULL
,	NULL
respectively	NULL
(	NULL
42	NULL
)	NULL
.	NULL

For	NULL
Bright	NULL
,	NULL
wM	NULL
is	NULL
calculated	NULL
to	NULL
be	NULL
0.41	NULL
and	NULL
uF	NULL
to	NULL
0.48	NULL
giving	NULL
a	NULL
ratio	NULL
of	NULL
0.85	NULL
.	NULL

Based	NULL
on	NULL
A-tract	NULL
standards	NULL
in	NULL
4	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
,	NULL
this	NULL
ratio	NULL
corresponds	NULL
to	NULL
a	NULL
distortion	NULL
angle	NULL
of	NULL
80-90°	NULL
.	NULL

Ep	NULL
,	NULL
Becomes	NULL
DNase	NULL
I	NULL
Hypersensitive	NULL
following	NULL
Bright	NULL
Over-expression-The	NULL
ability	NULL
of	NULL
Bright	NULL
to	NULL
mediate	NULL
specific	NULL
activation	NULL
of	NULL
integrated	NULL
binding	NULL
sites	NULL
and	NULL
to	NULL
distort	NULL
DNA	NULL
suggested	NULL
that	NULL
it	NULL
may	NULL
be	NULL
involved	NULL
with	NULL
altering	NULL
chromosomal	NULL
architecture	NULL
and	NULL
nucleosome-free	NULL
regions	NULL
of	NULL
DNA	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
coincide	NULL
with	NULL
nucleosome-free	NULL
regions	NULL
in	NULL
chromatin	NULL
.	NULL

To	NULL
test	NULL
the	NULL
ability	NULL
of	NULL
Bright	NULL
to	NULL
alter	NULL
the	NULL
chromosomal	NULL
organization	NULL
of	NULL
the	NULL
endogenous	NULL
IgH	NULL
locus	NULL
,	NULL
we	NULL
stably	NULL
transfected	NULL
Bright	NULL
into	NULL
a	NULL
murine	NULL
mature	NULL
B	NULL
cell	NULL
line	NULL
(	NULL
WEHI	NULL
231	NULL
)	NULL
that	NULL
produces	NULL
low	NULL
levels	NULL
of	NULL
endogenous	NULL
Bright	NULL
protein	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Following	NULL
a	NULL
20-day	NULL
culture	NULL
in	NULL
G418	NULL
,	NULL
we	NULL
selected	NULL
a	NULL
clone	NULL
that	NULL
expressed	NULL
Bright	NULL
at	NULL
levels	NULL
~8-fold	NULL
above	NULL
that	NULL
in	NULL
the	NULL
WEHI	NULL
231	NULL
parental	NULL
lane	NULL
and	NULL
about	NULL
twice	NULL
that	NULL
seen	NULL
in	NULL
two	NULL
Ig	NULL
M-secreting	NULL
plasmacytomas	NULL
(	NULL
MOPC	NULL
104E	NULL
and	NULL
HNK-1	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Nuclease	NULL
sensitivity	NULL
in	NULL
mock-transfected	NULL
WEHI	NULL
231	NULL
nuclei	NULL
was	NULL
limited	NULL
to	NULL
a	NULL
220-bp	NULL
region	NULL
coinciding	NULL
with	NULL
the	NULL
Ep	NULL
core	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
cells	NULL
ectopically	NULL
expressing	NULL
Bright	NULL
,	NULL
hypersensitivity	NULL
was	NULL
greater	NULL
in	NULL
magnitude	NULL
and	NULL
encompassed	NULL
a	NULL
significantly	NULL
larger	NULL
(	NULL
~500	NULL
bp	NULL
)	NULL
area	NULL
that	NULL
extended	NULL
through	NULL
the	NULL
5°	NULL
MAR	NULL
,	NULL
which	NULL
contains	NULL
the	NULL
high	NULL
affinity	NULL
P2	NULL
binding	NULL
site	NULL
of	NULL
Bright	NULL
.	NULL

A	NULL
modest	NULL
(	NULL
2-3-fold	NULL
)	NULL
increase	NULL
in	NULL
p	NULL
transcription	NULL
accompanied	NULL
this	NULL
effect	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
but	NULL
is	NULL
similar	NULL
to	NULL
the	NULL
level	NULL
of	NULL
u	NULL
induction	NULL
caused	NULL
by	NULL
antigen	NULL
+	NULL
inter	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
21328	NULL
Eu	NULL
schematic	NULL
A2	NULL
5°	NULL
MAR	NULL
labeled	NULL
Contextual	NULL
Requirements	NULL
for	NULL
the	NULL
Function	NULL
of	NULL
Bright	NULL
5°	NULL
MAR	NULL
core	NULL
3	NULL
'	NULL
MAR	NULL
PL	NULL
P2	NULL
octamer	NULL
P3	NULL
P4	NULL
Al	NULL
5°	NULL
MAR	NULL
M	NULL
3°	NULL
MAR	NULL
A3	NULL
3	NULL
'	NULL
MAR	NULL
Pome	NULL
UL	NULL
_	NULL
|	NULL
U	NULL
J	NULL
_	NULL
LC	NULL
poly	NULL
dIdC	NULL
/	NULL
'	NULL
]	NULL
/	NULL
’	NULL
]	NULL
Z/f	NULL
]	NULL
*	NULL
*	NULL
``	NULL
I|	NULL
Fic	NULL
.	NULL

3	NULL
.	NULL

Bright	NULL
interacts	NULL
with	NULL
specific	NULL
P	NULL
sites	NULL
in	NULL
Ep	NULL
,	NULL
ete	NULL
.	NULL

Electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
in	NULL
vitro-translated	NULL
Bright	NULL
and	NULL
labeled	NULL
AP	NULL
Ep	NULL
MAR	NULL
fragments	NULL
are	NULL
shown	NULL
.	NULL

A	NULL
schematic	NULL
of	NULL
the	NULL
four	NULL
MAR	NULL
fragments	NULL
used	NULL
as	NULL
probes	NULL
(	NULL
deletions	NULL
isolate	NULL
a	NULL
single	NULL
P	NULL
site	NULL
per	NULL
probe	NULL
)	NULL
are	NULL
shown	NULL
above	NULL
three	NULL
corresponding	NULL
lanes	NULL
that	NULL
contain	NULL
1	NULL
,	NULL
2.5	NULL
,	NULL
and	NULL
5	NULL
ug	NULL
of	NULL
poly	NULL
d	NULL
(	NULL
I-C	NULL
)	NULL
in	NULL
the	NULL
binding	NULL
reaction	NULL
.	NULL

Transient	NULL
transfection	NULL
Stable	NULL
transfection	NULL
-	NULL
ue	NULL
u	NULL
car	NULL
_	NULL
}	NULL
-A	NULL
[	NULL
_FeJ	NULL
arr	NULL
r	NULL
Fold	NULL
Transactivation	NULL
Fold	NULL
Transactivation	NULL
Fic	NULL
.	NULL

4	NULL
.	NULL

Bright	NULL
mediates	NULL
promoter-enhancer	NULL
and	NULL
matrix	NULL
interactions	NULL
.	NULL

J558L	NULL
cells	NULL
were	NULL
transfected	NULL
either	NULL
transiently	NULL
or	NULL
for	NULL
stable	NULL
integration	NULL
with	NULL
tk-CAT	NULL
vectors	NULL
containing	NULL
the	NULL
S107	NULL
promoter	NULL
fragment	NULL
upstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
and/or	NULL
Ep	NULL
or	NULL
AEp	NULL
downstream	NULL
of	NULL
the	NULL
CAT	NULL
gene	NULL
as	NULL
indicated	NULL
.	NULL

Results	NULL
are	NULL
expressed	NULL
as	NULL
fold	NULL
activation	NULL
as	NULL
described	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
are	NULL
the	NULL
average	NULL
of	NULL
four	NULL
separate	NULL
transfections	NULL
.	NULL

N.D.	NULL
,	NULL
not	NULL
determined	NULL
.	NULL

leukin	NULL
5	NULL
stimulation	NULL
(	NULL
14	NULL
,	NULL
15	NULL
)	NULL
.	NULL

A	NULL
stronger	NULL
and	NULL
more	NULL
extended	NULL
DNase	NULL
I	NULL
digestion	NULL
pattern	NULL
is	NULL
observed	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
in	NULL
nuclei	NULL
of	NULL
the	NULL
plasmacytomas	NULL
that	NULL
transcribe	NULL
the	NULL
u	NULL
locus	NULL
about	NULL
50-fold	NULL
higher	NULL
than	NULL
WEHI	NULL
231	NULL
(	NULL
see	NULL
Ref	NULL
.	NULL

6	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
endogenous	NULL
enhancer	NULL
assumes	NULL
a	NULL
more	NULL
extended	NULL
chromatin	NULL
configuration	NULL
as	NULL
a	NULL
direct	NULL
or	NULL
indirect	NULL
consequence	NULL
of	NULL
ectopic	NULL
Bright	NULL
overexpression	NULL
.	NULL

DISCUSSION	NULL
Herrscher	NULL
et	NULL
al	NULL
.	NULL

(	NULL
13	NULL
)	NULL
described	NULL
Bright	NULL
as	NULL
a	NULL
B	NULL
cell-specific	NULL
transcription	NULL
factor	NULL
capable	NULL
of	NULL
transactivating	NULL
expression	NULL
from	NULL
the	NULL
IgH	NULL
enhancer	NULL
(	NULL
Ep	NULL
)	NULL
.	NULL

In	NULL
this	NULL
report	NULL
we	NULL
have	NULL
characterized	NULL
the	NULL
contextual	NULL
requirements	NULL
of	NULL
Bright	NULL
transactivation	NULL
to	NULL
further	NULL
understand	NULL
how	NULL
it	NULL
,	NULL
and	NULL
potentially	NULL
other	NULL
MAR	NULL
binding	NULL
factors	NULL
,	NULL
can	NULL
affect	NULL
transcription	NULL
levels	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
support	NULL
several	NULL
mechanisms	NULL
for	NULL
Bright-mediated	NULL
transcriptional	NULL
regulation	NULL
.	NULL

Using	NULL
transient	NULL
transfection	NULL
analysis	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
context	NULL
is	NULL
important	NULL
for	NULL
Bright	NULL
transactivation	NULL
.	NULL

Bright	NULL
was	NULL
unable	NULL
to	NULL
transactivate	NULL
gene	NULL
expression	NULL
from	NULL
a	NULL
concatamerized	NULL
binding	NULL
site	NULL
,	NULL
suggesting	NULL
that	NULL
it	NULL
required	NULL
interaction	NULL
with	NULL
specific	NULL
factors	NULL
to	NULL
function	NULL
.	NULL

Furthermore	NULL
,	NULL
Bright	NULL
only	NULL
acts	NULL
through	NULL
the	NULL
P2	NULL
and	NULL
P4	NULL
sites	NULL
of	NULL
the	NULL
Ep	NULL
MARs	NULL
.	NULL

This	NULL
was	NULL
initially	NULL
surprising	NULL
,	NULL
because	NULL
Bright	NULL
binds	NULL
the	NULL
P3	NULL
site	NULL
as	NULL
strongly	NULL
as	NULL
P2	NULL
and	NULL
suggested	NULL
spatial	NULL
constraints	NULL
for	NULL
the	NULL
interactions	NULL
of	NULL
Bright	NULL
with	NULL
other	NULL
factors	NULL
.	NULL

This	NULL
suggested	NULL
that	NULL
Bright	NULL
might	NULL
function	NULL
to	NULL
form	NULL
tertiary	NULL
structures	NULL
of	NULL
the	NULL
enhancer	NULL
DNA	NULL
and	NULL
interact	NULL
with	NULL
additional	NULL
DNA-binding	NULL
proteins	NULL
or	NULL
adaptor	NULL
molecules	NULL
.	NULL

In	NULL
support	NULL
of	NULL
this	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
Bright	NULL
distorts	NULL
DNA	NULL
.	NULL

Studies	NULL
with	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
a-chain	NULL
enhancer	NULL
have	NULL
shown	NULL
the	NULL
requirement	NULL
for	NULL
DNA	NULL
bending	NULL
and	NULL
distortion	NULL
to	NULL
remodel	NULL
DNA	NULL
so	NULL
that	NULL
transcription	NULL
factors	NULL
whose	NULL
binding	NULL
sites	NULL
are	NULL
spatially	NULL
distant	NULL
can	NULL
interact	NULL
(	NULL
46	NULL
)	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
Bright	NULL
plays	NULL
a	NULL
similar	NULL
role	NULL
in	NULL
the	NULL
induced	NULL
immunoglobulin	NULL
expression	NULL
of	NULL
late	NULL
stage	NULL
B	NULL
cells	NULL
.	NULL

Synergy	NULL
between	NULL
promoter	NULL
and	NULL
enhancer	NULL
transactivation	NULL
in	NULL
both	NULL
the	NULL
transient	NULL
and	NULL
stable	NULL
transfections	NULL
suggest	NULL
an	NULL
additional	NULL
level	NULL
of	NULL
function	NULL
for	NULL
Bright	NULL
.	NULL

Because	NULL
Bright	NULL
exists	NULL
in	NULL
a	NULL
tetrameric	NULL
form	NULL
,	NULL
and	NULL
only	NULL
two	NULL
functional	NULL
chains	NULL
are	NULL
required	NULL
for	NULL
Bright	NULL
binding	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
assay	NULL
(	NULL
13	NULL
)	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
one	NULL
Bright	NULL
molecule	NULL
could	NULL
bind	NULL
two	NULL
sites	NULL
.	NULL

Indeed	NULL
,	NULL
these	NULL
studies	NULL
suggest	NULL
that	NULL
Bright	NULL
could	NULL
bring	NULL
an	NULL
enhancer	NULL
in	NULL
apposition	NULL
to	NULL
the	NULL
promoter	NULL
and	NULL
directly	NULL
affect	NULL
transcriptional	NULL
activation	NULL
.	NULL

610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Contextual	NULL
Requirements	NULL
for	NULL
the	NULL
Function	NULL
of	NULL
Bright	NULL
A	NULL
BamHI=Ba	NULL
EcoRV=RV	NULL
RsalRs	NULL
HindINi=Hd	NULL
EooRI=RI	NULL
Ba	NULL
B	NULL
®	NULL
start	NULL
Fic	NULL
.	NULL

5	NULL
.	NULL

Bright	NULL
distorts	NULL
DNA	NULL
on	NULL
binding	NULL
.	NULL

A	NULL
,	NULL
schematic	NULL
of	NULL
probes	NULL
used	NULL
to	NULL
create	NULL
the	NULL
circular	NULL
permutation	NULL
of	NULL
a	NULL
Bright	NULL
binding	NULL
site	NULL
(	NULL
P2	NULL
X	NULL
8	NULL
)	NULL
.	NULL

Digestion	NULL
of	NULL
a	NULL
tandem	NULL
sequence	NULL
with	NULL
the	NULL
indicated	NULL
restriction	NULL
enzymes	NULL
generates	NULL
a	NULL
series	NULL
of	NULL
equal	NULL
sized	NULL
fragments	NULL
(	NULL
485	NULL
bp	NULL
)	NULL
that	NULL
differ	NULL
only	NULL
in	NULL
the	NULL
location	NULL
of	NULL
the	NULL
binding	NULL
site	NULL
.	NULL

Ba	NULL
,	NULL
BamHI	NULL
;	NULL
Ea	NULL
,	NULL
Eael	NULL
;	NULL
RV	NULL
,	NULL
EcoRv	NULL
;	NULL
Rs	NULL
,	NULL
Rsal	NULL
;	NULL
Hd	NULL
,	NULL
HindIII	NULL
;	NULL
RJ	NULL
,	NULL
EcoRI	NULL
.	NULL

B	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
with	NULL
10	NULL
ng	NULL
of	NULL
in	NULL
vitro-translated	NULL
truncated	NULL
Bright	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
216-601	NULL
)	NULL
,	NULL
1	NULL
ug	NULL
poly	NULL
d	NULL
(	NULL
IC	NULL
)	NULL
,	NULL
and	NULL
labeled	NULL
circular	NULL
permutated	NULL
probes	NULL
.	NULL

Total	NULL
migration	NULL
distance	NULL
(	NULL
start-end	NULL
)	NULL
and	NULL
relative	NULL
mobilities	NULL
for	NULL
the	NULL
slower	NULL
middle-bound	NULL
complex	NULL
(	NULL
uM	NULL
)	NULL
and	NULL
the	NULL
faster	NULL
end-bound	NULL
complex	NULL
(	NULL
uE	NULL
)	NULL
are	NULL
shown	NULL
.	NULL

Plasmacytomas	NULL
nonB	NULL
WEHI	NULL
231	NULL
WEHI231	NULL
M104E	NULL
HNK-1	NULL
P38D1	NULL
&	NULL
&	NULL
Bow	NULL
*	NULL
<	NULL
-	NULL
(	NULL
at	NULL
14-	NULL
u	NULL
~A	NULL
5	NULL
“	NULL
ite	NULL
\	NULL
.	NULL

IJ	NULL
a	NULL
ar-	NULL
g	NULL
{	NULL
ii	NULL
BRIGHT	NULL
:	NULL
LOW	NULL
HIGH	NULL
MODERATE	NULL
NONE	NULL
Fic	NULL
.	NULL

6	NULL
.	NULL

Overexpression	NULL
of	NULL
Bright	NULL
is	NULL
accompanied	NULL
by	NULL
enhanced	NULL
and	NULL
extended	NULL
DNase	NULL
hypersensitivity	NULL
of	NULL
Ep	NULL
.	NULL

The	NULL
strategy	NULL
for	NULL
indirect	NULL
end	NULL
labeling	NULL
was	NULL
described	NULL
under	NULL
``	NULL
Experimental	NULL
Procedures	NULL
.	NULL
``	NULL

Hypersensitive	NULL
sites	NULL
,	NULL
mapped	NULL
by	NULL
reference	NULL
to	NULL
a	NULL
1.6-kb	NULL
Bg/II	NULL
restriction	NULL
fragment	NULL
spanning	NULL
Ep	NULL
,	NULL
were	NULL
detected	NULL
by	NULL
using	NULL
an	NULL
upstream	NULL
Xbal-EcoRI	NULL
220-bp	NULL
subfragment	NULL
as	NULL
a	NULL
hybridization	NULL
probe	NULL
.	NULL

Nuclei	NULL
,	NULL
isolated	NULL
from	NULL
the	NULL
indicated	NULL
cell	NULL
lines	NULL
,	NULL
were	NULL
digested	NULL
with	NULL
(	NULL
from	NULL
left	NULL
to	NULL
right	NULL
in	NULL
each	NULL
panel	NULL
)	NULL
0	NULL
,	NULL
0.5	NULL
,	NULL
1.0	NULL
,	NULL
or	NULL
2.0	NULL
ug/ml	NULL
DNase	NULL
I.	NULL
DNA	NULL
was	NULL
purified	NULL
,	NULL
cut	NULL
with	NULL
Bgill	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
Southern	NULL
blotting	NULL
.	NULL

Molecular	NULL
size	NULL
markers	NULL
are	NULL
indicated	NULL
to	NULL
the	NULL
left	NULL
.	NULL

Hypersensitive	NULL
positions	NULL
,	NULL
mapped	NULL
by	NULL
subtracting	NULL
the	NULL
fragment	NULL
size	NULL
from	NULL
the	NULL
parental	NULL
Bg/II	NULL
fragment	NULL
,	NULL
are	NULL
indicated	NULL
on	NULL
the	NULL
blots	NULL
and	NULL
superimposed	NULL
onto	NULL
a	NULL
vertical	NULL
schematic	NULL
of	NULL
Ep	NULL
.	NULL

This	NULL
effect	NULL
would	NULL
be	NULL
consistent	NULL
with	NULL
studies	NULL
that	NULL
have	NULL
implicated	NULL
the	NULL
IgH	NULL
enhancer	NULL
MARs	NULL
in	NULL
long	NULL
range	NULL
(	NULL
Ig	NULL
heavy	NULL
chain	NULL
variable	NULL
gene	NULL
segment	NULL
promoter-mediated	NULL
)	NULL
transcriptional	NULL
ac	NULL
21329	NULL
tivation	NULL
(	NULL
8	NULL
,	NULL
44	NULL
,	NULL
47	NULL
)	NULL
.	NULL

In	NULL
comparing	NULL
transgenic	NULL
p	NULL
expression	NULL
in	NULL
lines	NULL
generated	NULL
from	NULL
wild-type	NULL
and	NULL
MAR-deleted	NULL
Ep	NULL
con-structs	NULL
,	NULL
no	NULL
V	NULL
;	NULL
p-initiated	NULL
transcripts	NULL
were	NULL
detected	NULL
from	NULL
the	NULL
MAR-deleted	NULL
locus	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Using	NULL
a	NULL
different	NULL
approach	NULL
,	NULL
Artandi	NULL
et	NULL
al	NULL
.	NULL

(	NULL
48	NULL
)	NULL
demonstrated	NULL
that	NULL
TFE3	NULL
proteins	NULL
binding	NULL
in	NULL
the	NULL
Ig	NULL
promoter	NULL
and	NULL
enhancer	NULL
could	NULL
cooperate	NULL
when	NULL
binding	NULL
sites	NULL
were	NULL
placed	NULL
proximal	NULL
and	NULL
distal	NULL
of	NULL
a	NULL
CAT	NULL
gene	NULL
,	NULL
presumably	NULL
through	NULL
interaction	NULL
of	NULL
two	NULL
dimers	NULL
.	NULL

Bright	NULL
already	NULL
exists	NULL
as	NULL
a	NULL
tetramer	NULL
and	NULL
so	NULL
would	NULL
not	NULL
require	NULL
any	NULL
additional	NULL
protein-protein	NULL
interactions	NULL
to	NULL
carry	NULL
out	NULL
this	NULL
function	NULL
.	NULL

This	NULL
study	NULL
also	NULL
provides	NULL
functional	NULL
evidence	NULL
for	NULL
the	NULL
MAR	NULL
binding	NULL
function	NULL
of	NULL
Bright	NULL
.	NULL

Transient	NULL
transfections	NULL
with	NULL
the	NULL
S107	NULL
promoter	NULL
fragment	NULL
,	NULL
which	NULL
contains	NULL
a	NULL
MAR	NULL
(	NULL
45	NULL
)	NULL
,	NULL
demonstrated	NULL
that	NULL
Bright	NULL
was	NULL
unable	NULL
to	NULL
transactivate	NULL
from	NULL
this	NULL
site	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
when	NULL
this	NULL
construct	NULL
was	NULL
stably	NULL
transfected	NULL
,	NULL
Bright	NULL
was	NULL
now	NULL
able	NULL
to	NULL
affect	NULL
a	NULL
4-fold	NULL
increase	NULL
in	NULL
transcription	NULL
consistent	NULL
with	NULL
the	NULL
concept	NULL
that	NULL
MARs	NULL
only	NULL
have	NULL
effects	NULL
when	NULL
they	NULL
are	NULL
integrated	NULL
into	NULL
the	NULL
chromosome	NULL
.	NULL

We	NULL
previously	NULL
demonstrated	NULL
that	NULL
Bright	NULL
protein	NULL
can	NULL
be	NULL
matrix-associated	NULL
(	NULL
13	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
Bright	NULL
is	NULL
only	NULL
capable	NULL
of	NULL
transactivating	NULL
from	NULL
the	NULL
S107	NULL
promoter	NULL
only	NULL
when	NULL
it	NULL
is	NULL
integrated	NULL
suggests	NULL
that	NULL
Bright	NULL
can	NULL
function	NULL
by	NULL
modifying	NULL
or	NULL
mediating	NULL
matrix	NULL
attachment	NULL
.	NULL

One	NULL
difference	NULL
between	NULL
the	NULL
8107	NULL
plasmid	NULL
and	NULL
the	NULL
construct	NULL
with	NULL
Eu	NULL
in	NULL
the	NULL
proximal	NULL
position	NULL
,	NULL
which	NULL
can	NULL
mediate	NULL
transactivation	NULL
in	NULL
a	NULL
transient	NULL
assay	NULL
,	NULL
may	NULL
be	NULL
the	NULL
availability	NULL
of	NULL
other	NULL
interacting	NULL
co-factors	NULL
.	NULL

This	NULL
highlights	NULL
the	NULL
context-dependent	NULL
activity	NULL
of	NULL
Bright	NULL
.	NULL

Bright	NULL
may	NULL
interact	NULL
with	NULL
some	NULL
factors	NULL
during	NULL
a	NULL
transient	NULL
assay	NULL
and	NULL
allow	NULL
activation	NULL
from	NULL
Eu	NULL
,	NULL
whereas	NULL
matrix	NULL
attachment	NULL
is	NULL
required	NULL
for	NULL
transactivation	NULL
from	NULL
a	NULL
substrate	NULL
that	NULL
may	NULL
have	NULL
limited	NULL
DNA	NULL
binding	NULL
factors	NULL
associated	NULL
with	NULL
it	NULL
for	NULL
Bright	NULL
interaction	NULL
.	NULL

In	NULL
support	NULL
of	NULL
interactions	NULL
such	NULL
as	NULL
this	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
Bright	NULL
associates	NULL
with	NULL
members	NULL
of	NULL
the	NULL
Sp100	NULL
family	NULL
,	NULL
which	NULL
co-localize	NULL
with	NULL
Bright	NULL
in	NULL
nuclear	NULL
domains	NULL
and	NULL
act	NULL
as	NULL
co-factors	NULL
in	NULL
transactivation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
Bright	NULL
has	NULL
multiple	NULL
requirements	NULL
for	NULL
transactivation	NULL
activity	NULL
,	NULL
but	NULL
the	NULL
context-dependent	NULL
activity	NULL
may	NULL
also	NULL
provide	NULL
multiple	NULL
mechanisms	NULL
for	NULL
Bright	NULL
to	NULL
activate	NULL
gene	NULL
transcription	NULL
.	NULL

Ectopic	NULL
overexpression	NULL
of	NULL
Bright	NULL
revealed	NULL
an	NULL
altered	NULL
pattern	NULL
of	NULL
chromatin	NULL
organization	NULL
within	NULL
the	NULL
IgH	NULL
enhancer	NULL
in	NULL
WEHI	NULL
231	NULL
B	NULL
cell	NULL
nuclei	NULL
.	NULL

Consistent	NULL
with	NULL
previous	NULL
studies	NULL
(	NULL
44	NULL
,	NULL
47	NULL
,	NULL
49	NULL
)	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
untransfected	NULL
WEHI	NULL
231	NULL
nuclei	NULL
is	NULL
restricted	NULL
to	NULL
the	NULL
Eu	NULL
core	NULL
.	NULL

The	NULL
assembly	NULL
of	NULL
this	NULL
complex	NULL
,	NULL
as	NULL
judged	NULL
by	NULL
in	NULL
vivo	NULL
dimethyl	NULL
sulfate	NULL
methylation	NULL
patterns	NULL
,	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
independent	NULL
of	NULL
the	NULL
flanking	NULL
MARs	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Under	NULL
conditions	NULL
where	NULL
Bright	NULL
is	NULL
expressed	NULL
at	NULL
high	NULL
levels	NULL
,	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
appears	NULL
to	NULL
extend	NULL
upstream	NULL
,	NULL
to	NULL
include	NULL
the	NULL
high	NULL
affinity	NULL
P2	NULL
site-containing	NULL
MAR	NULL
,	NULL
but	NULL
not	NULL
downstream	NULL
of	NULL
the	NULL
core	NULL
.	NULL

This	NULL
third	NULL
,	NULL
highly	NULL
extended	NULL
configuration	NULL
extending	NULL
across	NULL
the	NULL
3	NULL
'	NULL
MAR	NULL
is	NULL
observed	NULL
in	NULL
the	NULL
two	NULL
Ig	NULL
M-secreting	NULL
plasmacytomas	NULL
that	NULL
transcribe	NULL
u	NULL
at	NULL
~50-fold	NULL
higher	NULL
levels	NULL
.	NULL

Similarly	NULL
,	NULL
the	NULL
Igx	NULL
3	NULL
'	NULL
enhancer	NULL
assumes	NULL
three	NULL
states	NULL
of	NULL
DNase	NULL
I	NULL
detectable	NULL
accessi-bility	NULL
,	NULL
which	NULL
correlate	NULL
strictly	NULL
with	NULL
stage	NULL
of	NULL
B	NULL
cell	NULL
development	NULL
(	NULL
50	NULL
)	NULL
.	NULL

That	NULL
the	NULL
Bright	NULL
overexpressing	NULL
cells	NULL
may	NULL
have	NULL
begun	NULL
to	NULL
transition	NULL
from	NULL
mature	NULL
to	NULL
activated	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
increased	NULL
Ep	NULL
accessibility	NULL
and	NULL
the	NULL
slightly	NULL
increased	NULL
levels	NULL
of	NULL
u	NULL
transcription	NULL
observed	NULL
here	NULL
and	NULL
with	NULL
the	NULL
appearance	NULL
of	NULL
active	NULL
Bright	NULL
:	NULL
MAR	NULL
binding	NULL
complexes	NULL
both	NULL
in	NULL
normal	NULL
B	NULL
cell	NULL
populations	NULL
and	NULL
in	NULL
B	NULL
cell	NULL
lines	NULL
observed	NULL
previously	NULL
(	NULL
13	NULL
,	NULL
19	NULL
)	NULL
.	NULL

Based	NULL
on	NULL
its	NULL
SWIl	NULL
similarities	NULL
,	NULL
nuclear	NULL
matrix	NULL
residence	NULL
,	NULL
and	NULL
MAR	NULL
bending	NULL
properties	NULL
,	NULL
it	NULL
is	NULL
tempting	NULL
to	NULL
consider	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
Bright	NULL
in	NULL
this	NULL
remodeling	NULL
.	NULL

However	NULL
,	NULL
both	NULL
known	NULL
classes	NULL
of	NULL
chromatin	NULL
remodeling	NULL
enzymes	NULL
,	NULL
SWI-SNF	NULL
and	NULL
the	NULL
histone	NULL
acetyltransferases	NULL
,	NULL
exist	NULL
as	NULL
large	NULL
multicomponent	NULL
,	NULL
ATP-hydro-lyzing	NULL
complexes	NULL
(	NULL
reviewed	NULL
in	NULL
Ref	NULL
.	NULL

36	NULL
)	NULL
.	NULL

We	NULL
have	NULL
no	NULL
evidence	NULL
for	NULL
or	NULL
against	NULL
participation	NULL
of	NULL
Bright	NULL
as	NULL
a	NULL
B	NULL
cell-restricted	NULL
member	NULL
or	NULL
recruiter	NULL
of	NULL
either	NULL
.	NULL

However	NULL
,	NULL
MARs	NULL
do	NULL
confer	NULL
local	NULL
regions	NULL
of	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
21330	NULL
histone	NULL
acetylation	NULL
(	NULL
51	NULL
)	NULL
.	NULL

In	NULL
a	NULL
different	NULL
target	NULL
gene	NULL
system	NULL
,	NULL
Cux	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
form	NULL
a	NULL
complex	NULL
with	NULL
histone	NULL
deacetylase	NULL
that	NULL
leads	NULL
to	NULL
gene	NULL
inactivation	NULL
(	NULL
52	NULL
)	NULL
.	NULL

Bright	NULL
could	NULL
mediate	NULL
de-repressive	NULL
chromatin	NULL
remodeling	NULL
indirectly	NULL
through	NULL
its	NULL
successful	NULL
competition	NULL
with	NULL
Cux/histone	NULL
deacetylase	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
logic	NULL
,	NULL
Bright	NULL
,	NULL
along	NULL
with	NULL
related	NULL
chromatin	NULL
remodeling	NULL
proteins	NULL
,	NULL
would	NULL
then	NULL
be	NULL
in	NULL
a	NULL
position	NULL
to	NULL
clear	NULL
out	NULL
regions	NULL
carrying	NULL
the	NULL
cis-acting	NULL
regulatory	NULL
elements	NULL
of	NULL
the	NULL
core	NULL
,	NULL
contributing	NULL
to	NULL
the	NULL
accessibility	NULL
of	NULL
conventional	NULL
DNA	NULL
binding	NULL
transactivators	NULL
to	NULL
promoter	NULL
and	NULL
enhancer	NULL
elements	NULL
.	NULL

Studies	NULL
presented	NULL
in	NULL
this	NULL
report	NULL
suggest	NULL
some	NULL
novel	NULL
mechanisms	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
immunoglobulin	NULL
gene	NULL
expression	NULL
.	NULL

They	NULL
confirm	NULL
that	NULL
Bright	NULL
acts	NULL
in	NULL
a	NULL
restricted	NULL
manner	NULL
by	NULL
binding	NULL
specific	NULL
sites	NULL
in	NULL
the	NULL
IgH	NULL
promoter	NULL
and	NULL
enhancer	NULL
and	NULL
by	NULL
potentially	NULL
interacting	NULL
with	NULL
other	NULL
factors	NULL
within	NULL
the	NULL
enhancer	NULL
core	NULL
.	NULL

It	NULL
further	NULL
provides	NULL
some	NULL
insight	NULL
into	NULL
the	NULL
mechanism	NULL
of	NULL
enhancer	NULL
function	NULL
and	NULL
more	NULL
specifically	NULL
,	NULL
how	NULL
Bright	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
Ig	NULL
gene	NULL
expression	NULL
.	NULL

Further	NULL
analysis	NULL
of	NULL
these	NULL
Bright	NULL
new	NULL
alternatives	NULL
should	NULL
yield	NULL
a	NULL
greater	NULL
understanding	NULL
of	NULL
long-standing	NULL
questions	NULL
regarding	NULL
gene	NULL
regulation	NULL
.	NULL

Acknowledgments-We	NULL
thank	NULL
Chhaya	NULL
Das	NULL
for	NULL
technical	NULL
assistance	NULL
and	NULL
Utpal	NULL
Das	NULL
for	NULL
preparation	NULL
of	NULL
this	NULL
manuscript	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Ernst	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Smale	NULL
,	NULL
S.	NULL
T.	NULL
(	NULL
1995	NULL
)	NULL
Immunity	NULL
2	NULL
,	NULL
427-438	NULL
2	NULL
.	NULL

Adams	NULL
,	NULL
J.	NULL
M.	NULL
,	NULL
Harris	NULL
,	NULL
A.	NULL
W.	NULL
,	NULL
Pinkert	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
Corcoran	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
Alexander	NULL
,	NULL
W.	NULL
S.	NULL
,	NULL
Cory	NULL
,	NULL
S.	NULL
,	NULL
Palmiter	NULL
,	NULL
R.	NULL
D.	NULL
,	NULL
and	NULL
Brinster	NULL
,	NULL
R.	NULL
L.	NULL
(	NULL
1985	NULL
)	NULL
Nature	NULL
818	NULL
,	NULL
588-541	NULL
3	NULL
.	NULL

Banerji	NULL
,	NULL
J.	NULL
,	NULL
Olson	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Schaffner	NULL
,	NULL
W.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
88	NULL
,	NULL
729-740	NULL
4	NULL
.	NULL

Cockerill	NULL
,	NULL
P.	NULL
N.	NULL
,	NULL
Yuen	NULL
.	NULL

M.-H.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T	NULL
(	NULL
1987	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262	NULL
,	NULL
5394-5397	NULL
5	NULL
.	NULL

Gillies	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
Morrison	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
Oi	NULL
,	NULL
V.	NULL
T.	NULL
,	NULL
and	NULL
Tonegawa	NULL
,	NULL
S.	NULL
(	NULL
1983	NULL
)	NULL
Cell	NULL
33	NULL
,	NULL
717-728	NULL
.	NULL

Kiledjian	NULL
,	NULL
M.	NULL
,	NULL
Su	NULL
,	NULL
L.	NULL
K.	NULL
,	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
,	NULL
145-152	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
,	NULL
Pierce	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
(	NULL
1987	NULL
)	NULL
Science	NULL
286	NULL
,	NULL
1573-1577	NULL
.	NULL

Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
van	NULL
Genderen	NULL
,	NULL
C.	NULL
,	NULL
Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Grossched	NULL
]	NULL
,	NULL
R.	NULL
(	NULL
1994	NULL
)	NULL
Science	NULL
265	NULL
,	NULL
1221-1225	NULL
9	NULL
.	NULL

Genetta	NULL
,	NULL
T.	NULL
,	NULL
Ruezinsky	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Kadesch	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
6153-6163	NULL
10	NULL
.	NULL

Imler	NULL
,	NULL
J.-L.	NULL
,	NULL
Lemaire	NULL
,	NULL
C.	NULL
,	NULL
Wasylyk	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Wasylyk	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1987	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

7	NULL
,	NULL
2558-2567	NULL
11	NULL
.	NULL

Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Chen	NULL
,	NULL
U	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

8	NULL
,	NULL
1255-1266	NULL
12	NULL
.	NULL

Weinberger	NULL
,	NULL
J.	NULL
,	NULL
Jat	NULL
,	NULL
P.	NULL
S.	NULL
,	NULL
and	NULL
Sharp	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

8	NULL
,	NULL
988-992	NULL
13	NULL
.	NULL

Herrscher	NULL
,	NULL
R.	NULL
F.	NULL
,	NULL
Kaplan	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Lelsz	NULL
,	NULL
D.	NULL
L.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
Scheuermann	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
3067-3082	NULL
14	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
Coffman	NULL
,	NULL
R.	NULL
L.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

148	NULL
,	NULL
3934-3939	NULL
15	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
Eaton	NULL
,	NULL
S.	NULL
,	NULL
Calame	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5197-5205	NULL
16	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Yamashita	NULL
,	NULL
Y.	NULL
,	NULL
Ayers	NULL
,	NULL
N.	NULL
,	NULL
Evetts	NULL
,	NULL
S.	NULL
,	NULL
Paulin	NULL
,	NULL
Y.	NULL
,	NULL
Conley	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
and	NULL
Smith	NULL
,	NULL
E.	NULL
A	NULL
.	NULL

(	NULL
2000	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

165	NULL
,	NULL
6956-6965	NULL
17	NULL
.	NULL

Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Job	NULL
,	NULL
T.	NULL
,	NULL
Kohwi	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
631-645	NULL
18	NULL
.	NULL

Wang	NULL
,	NULL
Z.	NULL
,	NULL
Goldstein	NULL
,	NULL
A.	NULL
,	NULL
Zong	NULL
,	NULL
R.-T.	NULL
,	NULL
Lin	NULL
,	NULL
D.	NULL
,	NULL
Neufeld	NULL
,	NULL
J.	NULL
E.	NULL
,	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1999	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

19	NULL
,	NULL
284-295	NULL
go	NULL
~1	NULL
®	NULL
Contextual	NULL
Requirements	NULL
for	NULL
the	NULL
Function	NULL
of	NULL
Bright	NULL
19	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Smith	NULL
,	NULL
F.	NULL
A.	NULL
,	NULL
Medina	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Buchanan	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
Smithson	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dou	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J.	NULL
Immunol	NULL
.	NULL

160	NULL
,	NULL
4747-4754	NULL
20	NULL
.	NULL

Zong	NULL
,	NULL
R.-T.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
2000	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

19	NULL
,	NULL
4123-4133	NULL
21	NULL
.	NULL

Adachi	NULL
,	NULL
Y.	NULL
,	NULL
Kas	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

8	NULL
,	NULL
3997-4006	NULL
22	NULL
.	NULL

Hofmann	NULL
,	NULL
J	NULL
.	NULL

F.-X	NULL
.	NULL

,	NULL
Laroche	NULL
,	NULL
T.	NULL
,	NULL
Brand	NULL
,	NULL
A.	NULL
H.	NULL
,	NULL
and	NULL
Gasser	NULL
,	NULL
S.	NULL
M.	NULL
(	NULL
1989	NULL
)	NULL
Cell	NULL
57	NULL
,	NULL
725-737	NULL
23	NULL
.	NULL

Izaurralde	NULL
,	NULL
E.	NULL
,	NULL
Kas	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1989	NULL
)	NULL
J.	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

210	NULL
,	NULL
573-585	NULL
24	NULL
.	NULL

Luderas	NULL
,	NULL
M.	NULL
E.	NULL
,	NULL
de	NULL
Graaf	NULL
,	NULL
A.	NULL
,	NULL
Mattia	NULL
,	NULL
E.	NULL
,	NULL
den	NULL
Blaauwen	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Grande	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
de	NULL
Jong	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
van	NULL
Driel	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
70	NULL
,	NULL
949-959	NULL
25	NULL
.	NULL

Nakagomi	NULL
,	NULL
K.	NULL
,	NULL
Kohwi	NULL
,	NULL
Y.	NULL
,	NULL
Dickinson	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
and	NULL
Kohwi-Shigematsu	NULL
,	NULL
T.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
1852-1860	NULL
26	NULL
.	NULL

Romig	NULL
,	NULL
H.	NULL
,	NULL
Fackelmayer	NULL
,	NULL
F.	NULL
O.	NULL
,	NULL
Renz	NULL
,	NULL
A.	NULL
,	NULL
Ramsperger	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Richter	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

11	NULL
,	NULL
3431-3440	NULL
27	NULL
.	NULL

Tsutsui	NULL
,	NULL
K.	NULL
,	NULL
Okada	NULL
,	NULL
S.	NULL
,	NULL
Watarai	NULL
,	NULL
S.	NULL
,	NULL
Seki	NULL
,	NULL
S.	NULL
,	NULL
Yasuda	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Shobmori	NULL
,	NULL
T.	NULL
(	NULL
1993	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
,	NULL
12886-12894	NULL
28	NULL
.	NULL

Zhao	NULL
,	NULL
K.	NULL
,	NULL
Kas	NULL
,	NULL
E.	NULL
,	NULL
Gonzalez	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
3237-3247	NULL
29	NULL
.	NULL

Zong	NULL
,	NULL
R.-T.	NULL
,	NULL
and	NULL
Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
(	NULL
1995	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
,	NULL
24010-24018	NULL
30	NULL
.	NULL

Scheuermann	NULL
,	NULL
R.	NULL
H.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1999	NULL
)	NULL
Crit	NULL
.	NULL

Rev	NULL
.	NULL

Eukaryotic	NULL
Gene	NULL
Expression	NULL
9	NULL
,	NULL
295-310	NULL
31	NULL
.	NULL

K	NULL
#	NULL
s	NULL
,	NULL
E.	NULL
,	NULL
Polijak	NULL
,	NULL
L.	NULL
,	NULL
Adachi	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
(	NULL
1998	NULL
)	NULL
EMBO	NULL
J	NULL
.	NULL

12	NULL
,	NULL
115-126	NULL
32	NULL
.	NULL

Pemov	NULL
,	NULL
A.	NULL
,	NULL
Bavykin	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Hamlin	NULL
,	NULL
J.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sei	NULL
.	NULL

U.	NULL
S.	NULL
A	NULL
.	NULL

95	NULL
,	NULL
14757-14762	NULL
33	NULL
.	NULL

Singh	NULL
,	NULL
L.	NULL
,	NULL
Panicker	NULL
,	NULL
S.	NULL
G.	NULL
,	NULL
Nagaraj	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Majumdar	NULL
,	NULL
K.	NULL
C.	NULL
(	NULL
1994	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

22	NULL
,	NULL
2289-2295	NULL
34	NULL
.	NULL

Stein	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
van	NULL
Wijnen	NULL
,	NULL
A.	NULL
J.	NULL
,	NULL
Stein	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
Lian	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
,	NULL
Pockwinse	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
McNeil	NULL
,	NULL
S.	NULL
(	NULL
1998	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
.	NULL

Biochem	NULL
.	NULL

70	NULL
,	NULL
200-212	NULL
35	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
,	NULL
Zong	NULL
,	NULL
R.-T.	NULL
,	NULL
Lin	NULL
,	NULL
D.	NULL
,	NULL
Wang	NULL
,	NULL
Z.	NULL
,	NULL
Kaplan	NULL
,	NULL
M.	NULL
,	NULL
Paulin	NULL
,	NULL
Y.	NULL
,	NULL
Smith	NULL
,	NULL
E.	NULL
,	NULL
Probst	NULL
,	NULL
L.	NULL
,	NULL
Bryant	NULL
,	NULL
J.	NULL
,	NULL
Goldstein	NULL
,	NULL
A.	NULL
,	NULL
Scheuermann	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
(	NULL
1999	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

64	NULL
,	NULL
109-118	NULL
36	NULL
.	NULL

Peterson	NULL
,	NULL
C.	NULL
L.	NULL
(	NULL
1998	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

68	NULL
,	NULL
545-552	NULL
37	NULL
.	NULL

Dallas	NULL
,	NULL
P.	NULL
B.	NULL
,	NULL
Cheney	NULL
,	NULL
I.	NULL
W.	NULL
,	NULL
Liao	NULL
,	NULL
D.-W.	NULL
,	NULL
Bowrin	NULL
,	NULL
V.	NULL
,	NULL
Byam	NULL
,	NULL
W.	NULL
,	NULL
Pacchione	NULL
,	NULL
S.	NULL
,	NULL
Kobayashi	NULL
,	NULL
R.	NULL
,	NULL
Yaciuk	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Moran	NULL
,	NULL
E.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Biol	NULL
.	NULL

Cell	NULL
18	NULL
,	NULL
3596-3603	NULL
38	NULL
.	NULL

Reyes	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
Muchardt	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Yaniv	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
J	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

187	NULL
,	NULL
263-274	NULL
39	NULL
.	NULL

Schnitzer	NULL
,	NULL
G.	NULL
R.	NULL
,	NULL
Sif	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Kingston	NULL
,	NULL
R.	NULL
E.	NULL
(	NULL
1988	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

68	NULL
,	NULL
585-548	NULL
40	NULL
.	NULL

Ariizumi	NULL
,	NULL
K.	NULL
,	NULL
Ghosh	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

18	NULL
,	NULL
5629-5636	NULL
41	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
Cox	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Grossched	NULL
]	NULL
,	NULL
R.	NULL
(	NULL
1992	NULL
)	NULL
Cell	NULL
69	NULL
,	NULL
185-195	NULL
42	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
and	NULL
Landy	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

16	NULL
,	NULL
9687-9705	NULL
43	NULL
.	NULL

Blasquez	NULL
,	NULL
V.	NULL
C.	NULL
,	NULL
Hale	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
Trevorrow	NULL
,	NULL
K.	NULL
W.	NULL
,	NULL
and	NULL
Garrard	NULL
,	NULL
W.	NULL
T.	NULL
(	NULL
1992	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
,	NULL
28888-23898	NULL
44	NULL
.	NULL

Jenuwein	NULL
,	NULL
T.	NULL
,	NULL
Forrester	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
Fernandez-Herrero	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Laible	NULL
,	NULL
G.	NULL
,	NULL
Dull	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Grossched1	NULL
,	NULL
R.	NULL
(	NULL
1997	NULL
)	NULL
Nature	NULL
885	NULL
,	NULL
269-281	NULL
45	NULL
.	NULL

Webb	NULL
,	NULL
C.	NULL
F.	NULL
,	NULL
Das	NULL
,	NULL
C.	NULL
,	NULL
Eneff	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
Tucker	NULL
,	NULL
P.	NULL
W.	NULL
(	NULL
1991	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

11	NULL
,	NULL
5206-5211	NULL
46	NULL
.	NULL

Giese	NULL
,	NULL
K.	NULL
,	NULL
Kingsley	NULL
,	NULL
C.	NULL
,	NULL
Kirshner	NULL
,	NULL
J.	NULL
R.	NULL
,	NULL
and	NULL
R.	NULL
(	NULL
1995	NULL
)	NULL
Genes	NULL
Dev	NULL
.	NULL

9	NULL
,	NULL
995-1008	NULL
47	NULL
.	NULL

Fernandez	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Winkler	NULL
,	NULL
M.	NULL
,	NULL
Forrester	NULL
,	NULL
W.	NULL
,	NULL
and	NULL
Grossched1	NULL
,	NULL
R.	NULL
(	NULL
1998	NULL
)	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

68	NULL
,	NULL
515-524	NULL
48	NULL
.	NULL

Artandi	NULL
,	NULL
S.	NULL
E.	NULL
,	NULL
Cooper	NULL
,	NULL
C.	NULL
,	NULL
Shrivastava	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Calame	NULL
,	NULL
K.	NULL
(	NULL
1994	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14	NULL
,	NULL
7704-7716	NULL
49	NULL
.	NULL

Ephrussi	NULL
,	NULL
A.	NULL
,	NULL
Church	NULL
,	NULL
G.	NULL
,	NULL
Tonegawa	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Gilbert	NULL
,	NULL
W.	NULL
(	NULL
1985	NULL
)	NULL
Science	NULL
227	NULL
,	NULL
134-0138	NULL
50	NULL
.	NULL

Roque	NULL
,	NULL
M.	NULL
C.	NULL
,	NULL
Smith	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Blasquez	NULL
,	NULL
V.	NULL
C.	NULL
(	NULL
1996	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
,	NULL
3138-3155	NULL
51	NULL
.	NULL

Fernandez	NULL
,	NULL
L.	NULL
A.	NULL
,	NULL
Winkler	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Grosschedl	NULL
,	NULL
R.	NULL
(	NULL
2001	NULL
)	NULL
Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

21	NULL
,	NULL
196-208	NULL
52	NULL
.	NULL

Li	NULL
,	NULL
S.	NULL
,	NULL
Moy	NULL
,	NULL
L.	NULL
,	NULL
Pittman	NULL
,	NULL
N.	NULL
,	NULL
Shue	NULL
,	NULL
G.	NULL
,	NULL
Aufiero	NULL
,	NULL
B.	NULL
,	NULL
Neufeld	NULL
,	NULL
E.	NULL
J.	NULL
,	NULL
LeLeiko	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
and	NULL
Walsh	NULL
,	NULL
M.	NULL
J	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

274	NULL
,	NULL
7808-7815	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL
Transcriptional	NULL
Activation	NULL
by	NULL
a	NULL
Matrix	NULL
Associating	NULL
Region-binding	NULL
Protein	NULL
:	NULL
CONTEXTUAL	NULL
REQUIREMENTS	NULL
FOR	NULL
THE	NULL
FUNCTION	NULL
OF	NULL
BRIGHT	NULL
Mark	NULL
H.	NULL
Kaplan	NULL
,	NULL
Rui-Ting	NULL
Zong	NULL
,	NULL
Richard	NULL
F.	NULL
Herrscher	NULL
,	NULL
Richard	NULL
H.	NULL
Scheuermann	NULL
and	NULL
Philip	NULL
W.	NULL
Tucker	NULL
J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

2001	NULL
,	NULL
276:21325-21330.	NULL
doi	NULL
:	NULL
10.1074/jbc.M100836200	NULL
originally	NULL
published	NULL
online	NULL
April	NULL
6	NULL
,	NULL
2001	NULL
Access	NULL
the	NULL
most	NULL
updated	NULL
version	NULL
of	NULL
this	NULL
article	NULL
at	NULL
doi	NULL
:	NULL
10.1074/jbe.M100836200	NULL
Alerts	NULL
:	NULL
«	NULL
When	NULL
this	NULL
article	NULL
is	NULL
cited	NULL
«	NULL
When	NULL
a	NULL
correction	NULL
for	NULL
this	NULL
article	NULL
is	NULL
posted	NULL
Click	NULL
here	NULL
to	NULL
choose	NULL
from	NULL
all	NULL
of	NULL
JBC	NULL
's	NULL
e-mail	NULL
alerts	NULL
This	NULL
article	NULL
cites	NULL
52	NULL
references	NULL
,	NULL
32	NULL
of	NULL
which	NULL
can	NULL
be	NULL
accessed	NULL
free	NULL
at	NULL
http	NULL
:	NULL
//www	NULL
325.	NULL
full.html	NULL
#	NULL
ref-list-1	NULL
610Z	NULL
'01	NULL
Aepy	NULL
uo	NULL
1san8	NULL
4g	NULL
/S10-aqf	NULL
/	NULL
wroj	NULL
;	NULL

